OncoLog MD Anderson's Report to Physicians (All issues)

Follow

• 

  OncoLog, Volume 63, Number 08, August 2018

  Angie N. Meus, Joe Munch, and Bryan Tutt

  • High-Dose Radiation Therapy for Pancreatic Cancer: trial tests whether radiomodulating agent GC4419 can enable higher doses of stereotactic body radiation therapy
  • Image-Guided Cordotomy for Cancer Pain: Computed tomography-guided cordotomy relieves cancer-related refractory pain
  • Esophageal, Pharyngoesophageal Reconstruction: Advanced surgical techniques restore digestive continuity
  • Therapy Preserves Swallowing Function: New trial tests different swallowing therapy regimens for head and neck cancer patients undergoing radiation therapy
  • OncoLog Says Farewell

• 

  OncoLog, Volume 63, Number 07, July 2018

  Sarah Bronson and Bryan Tutt

  • FGFR Inhibition for Bladder Cancer: Erdafitinib has favorable response rate in advanced bladder cancers, including those that do not respond to immunotherapy
  • INBRIEF: Targeted Therapies Matched to Tumor-Specific Mutations Prolong Survival
  • Managing High-Risk Breast Lesions: Strong provider recommendation for preventive therapy increases its use in women with lobular carcinoma in situ, atypical hyperplasia
  • Aerosolized Gemcitabine for Pulmonary Metastases: Clinical trials tests novel chemotherapy delivery system for patients with lung metastases from osteosarcoma or other solid tumors
  • HOUSE CALL: What the national Cancer Institute Does- Resources for cancer patients, caregivers, physicians, researchers

• 

  OncoLog, Volume 63, Number 05-06, May - June 2018

  Joe Munch, Sunita Patterson, and Bryan Tutt

  • Breast Cancer Treatment without Surgery: New approach may let certain breast cancer patients who respond to systemic therapy forgo surgery
  • INBRIEF: Targeted Drug BLU-667 Shows Promise against Solid Tumors with RET Alterations
  • Diet May Improve Gut Microbiome in Colorectal Cancer Survivors: Trial tests whether adding beans to diet affects markers of cancer risk, metabolic health
  • TRK Inhibition Shows Activity in Solid Tumors: Early results of clinical trials for adult, pediatric patients with NTRK gene fusions show promise
  • HOUSE CALL: Preparing for Natural Disasters-People with cancer or other chronic illnesses should take extra precautions

• 

  OncoLog, Volume 63, Number 04, April 2018

  Joe Munch, Bryan Tutt, and Sarah Bronson

  • Hunger Training Helps Manage Weight, May Reduce Cancer Risk: Clinical Trial tests weight loss strategy to reduce cancer risk in obese participants
  • Re-Irradiation for Recurrent Head and Neck cancer: Stereotactic techniques enable re-irradiation of unresectable tumors
  • Dermoscopy for Early Detection of Melanoma. Other Skin Cancers: MD Anderson physicians train clinicians in underserved areas to use dermoscopy, which can help avoid unnecessary biopsy
  • HOUSE CALL: Alcohol-Related cancers-Drinking alcohol increases risk of several types of cancer

• 

  OncoLog, Volume 63. Number 03, March 2018

  Bryan Tutt

  • Local Consolidative Therapy Plus Immunotherapy or Targeted Agents for NSCLC: Clinical trials explore surgery/radiation plus immune checkpoint or tyrosine kinase inhibitors for metastatic non-small cell lung cancer
  • INBRIEF: CAR T Cells Elicit Durable Responses in Large B Cell Lymphoma
  • Managing Opioid Use in Cancer Patients: Vigilance and interventions ensure patient safety
  • Hepatitis C Virus Linked to Head and Neck Cancers: Association of HCV with extrahepatic cancers has implications for HCV testing, treatment
  • HOUSE CALL: Understanding cancer Risk and Risk factors-Your risk factors might affect your need for cancer screening

• 

  OncoLog, Volume 63, Number 02, February 2018

  Sarah Bronson and Bryan Tutt

  • Radiation Therapy for Liver Cancer: Clinical trials expand treatment options for patients with primary liver cancer
  • Proton Therapy for Breast Cancer May Avoid Heart Damage: Trial compares cardiotoxicity of proton-and photon-based radiation therapy to the breast/chest wall and lymph nodes
  • New targeted Therapies for Leukemia: New treatments target CD123, BCL2 proteins in acute myelogenous leukemia, blastic plasmacytoid dendritic cell neoplasm
  • HOUSE CALL: Supportive Care for Cancer Patients- Supportive care treats the whole patient, not just the cancer

• 

  OncoLog, Volume 63, Number 01, January 2018

  Bryan Tutt

  • Immunotherapy for Genitourinary Cancers: Clinical trials explore immune checkpoint inhibitors for bladder, kidney, prostate cancers
  • Active Surveillance for Ductal Carcinoma in Situ: COMET trial compares frequent mammography to standard treatment with surgery
  • Radiation Plus Chemotherapy for Nasal NK T Cell Lymphoma: Clinical trial may standardize treatment for rare cancer
  • HOUSE CALL: Mammography Is Essential for Breast cancer Screening- FDA warns against clinics that advertise screening without mammography
  • USEFULRESOURCES: Videoconferences Allow Collaboration in Cancer Prevention, Treatment, Survivorship

• 

  OncoLog, Volume 62, Number 11-12, November - December 2017

  Joe Munch and Bryan Tutt

  • Managing Chemotherapy-Induced Neuropathy: Neuromodulation, pharmacological treatments show promise against peripheral neuropathy in cancer patients.
  • Treating Tobacco Addiction: MD Anderson provides pharmacotherapy, counseling to help smokers quit plus cessation education, resources for community practitioners
  • HOUSE CALL: Smoking-Related Cancers- Cancer risks from tobacco are not limited to the lungs, but quitting reduces these risks

• 

  OncoLog, Volume 62, Number 10, October 2017

  Sarah Bronson and Bryan Tutt

  • Organ-Sparing Therapy for Esophageal Cancer: Endoscopic surgery, ablation treat early-stage cancer, dysplasia while avoiding esophagectomy.
  • INBRIEF: Surgeons Perform Unique Allogeneic Soft Tissue Transplant Between Identical Twins
  • Advances in Breast Reconstruction: New reconstruction techniques increase breast cancer surgical options, improve cosmetic outcomes.
  • HOUSE CALL: Facing the Financial Burden of Cancer Treatment-Talking to care team, seeking out resources are important steps in managing cancer-related financial stress
  • INBRIEF: Proton Therapy plus Chemotherapy Shows Promise in Lung Cancer Trial

• 

  OncoLog, Volume 62, Number 09, September 2017

  Joe Munch and Bryan Tutt

  • Laser Interstitial Thermal Therapy for Spinal Metastases: Laser technique may be alternative to open surgery prior to stereotactic radiation therapy for metastases adjacent to the spinal cord.
  • Immunotherapy Plus Targeted Therapy for Anaplastic Thyroid Cancer: Trial combines atezolizumab with targeted or cytotoxic agents for patients with anaplastic or poorly differentiated thyroid cancer.
  • A New era in Follicular Lymphoma: Newly approved drugs, clinical trials represent shift from cytotoxic to targeted and immunotherapeutic agents.
  • HOUSE CALL: Understanding Clinical Trials- Trials provide access to new cancer treatments
  • INBRIEF: Repeat Surgery for Close Margins May Be Unnecessary for DCIS Patients Receiving Radiation Therapy

• 

  OncoLog, Volume 62, Number 08, August 2017

  Bryan Tutt and Sarah Bronson

  • Immunotherapy for Smoldering Myeloma: Clinical trials test PD-1, DC38 inhibitors to delay progression from premalignant disease to multiple myeloma.
  • Malignant Pheochromocytoma and Sympathetic Paraganglioma Research: Studies may expand treatment options for patients with rare neuroendocrine tumors.
  • Hypofractionated Partial-Breast Irradiation: Clinical trial tests 10-day external-beam radiation therapy regimen after lumpectomy for patients with early-stage breast cancer.
  • HOUSE CALL: Support for Cancer Patients: Patients, caregivers find many types of support from various organizations

• 

  OncoLog, Volume 62, Number 07, July 2017

  Joe Munch and Bryan Tutt

  • RAS Mutations and Colorectal Cancer Liver Metastases: Gene mutations may have implications for local therapy for liver metastases from colorectal cancer.
  • Active Surveillance for Prostate Cancer: Clinical trial may clarify which patients with prostate cancer will benefit from active surveillance rather than immediate treatment.
  • Gut Microbiome May Affect Immunotherapy Response in Melanoma: Metastatic melanoma patients who experience responses to checkpoint inhibitors have a distinct gut bacterial genetic signature.
  • HOUSE CALL: Cancer-Related fatigue-Tips for fighting fatigue

• 

  OncoLog, Volume 62, Number 05-06, May - June 2017

  Joe Munch, Bryan Tutt, and Kathryn Hale

  • Chimeric Antigen Receptor-Directed Natural Killer Cells for B Cell Malignancies: New take on an experimental therapy holds promise for patients with acute lymphoblastic leukemia, chronic lymphocytic leukemia, other lymphoid cancers.
  • Preoperative Exercise Program for Pancreatic Cancer Patients: Prehabilitation regimen to improve functional status during chemotherapy evaluated in clinical trials.
  • Neoadjuvant Immunotherapy for Non-Small Cell Lung Cancer: Clinical Trial will evaluate immune checkpoint inhibitors in patients with operable early-stage disease.
  • HOUSE CALL: Genetic Screening for Hereditary Cancer Syndromes: Genetic counseling, testing help people assess, manage cancer risk

• 

  OncoLog, Volume 62, Number 04, April 2017

  Bryan Tutt and Sarah Bronson

  • Advances in Surgical Management of Lymphedema: New options reduce edema in limbs, improve quality of life for cancer patients with lymphedema.
  • Noncytotoxic First-Line Therapy for Mantle Cell Lymphoma: First-line therapy with targeted and immunotherapy agents produces high response rates in mantle cell lymphoma.
  • Reports from the Survivorship Research Symposium: Research on BK virus, heart failure, and aspiration in cancer survivors.
  • HOUSE CALL: Types of Immunotherapy for Cancer: Understanding different approaches to immunotherapy

• 

  OncoLog, Volume 62, Number 03, March 2017

  Bryan Tutt, Joe Munch, and Brandon C. Strubberg

  • Immunotherapy for Glioblastoma: Clinical trials test innovative immunotherapy approaches against brain tumors.
  • Virus-Specific T Cells Treat Posttransplant Infections: Banked T cells offer "off-the-shelf" therapy for patients with BK virus, JC virus, Cytomegalovirus infections after stem cell transplant.
  • Intensity-Modulated Proton Therapy for Oropharyngeal Cancer: Clinical trial compares outcomes of intensity-modulated proton therapy, standard radiation therapy.
  • HOUSE CALL: Lung Cancer Screening-Low-dose computed tomography can detect lung cancer early

• 

  OncoLog, Volume 62, Number 02, February 2017

  Jill Deisigne-Russell, Christina Bennett, and Laura Russell

  • Fallopian Tube Removal May Reduce Ovarian Cancer Risk: Alternative approach to prophylactic surgery for women with BRCA mutations averts early menopause.
  • Highlights from the 2016 San Antonio Breast Cancer Symposium: MD Anderson researchers present findings regarding diagnosis, staging, treatment.
  • INBRIEF: Locoregional Restaging of Newly Diagnosed Breast Cancer with Mammography and Ultrasonography May Help Detect Additional Lesions
  • HOUSE CALL: Stem Cell Transplant Terms: Helpful definitions for patients and families
  • USEFUL RESOURCES: Algorithms for Managing Treatment-Related Conditions

• 

  OncoLog, Volume 62, Number 01, January 2017

  Bryan Tutt, Joe Munch, and Z Ahmed

  • Neoadjuvant Immunotherapy for Melanoma: Trial investigates immune checkpoint blockade in patients with respectable stage III or oligometastatic stage IV disease.
  • Radiation May Enhance Immunotherapy for Solid Tumors: Clinical Trials combine immune checkpoint inhibitors with radiation therapy against lung cancers, other solid tumors.
  • INBRIEF: Nivolumab Plus Azacitidine Shows Promise in Relapsed Acute Myelogenous Leukemia/ Acute Myelogenous Leukemia, Myelodysplastic Syndrome Study Questions Standard Exclusion Criteria for Conventional Trials
  • HOUSE CALL: Social Media Groups for Cancer Patients-Twitter chats, online groups for patients, caregivers
  • USEFUL RESOURCES: Resources to Aid Referring Physicians

• 

  OncoLog, Volume 61, Number 11-12, November - December 2016

  Brandon C. Strubberg, Sarah Bronson, Stephanie Deming, and E Nielsen

  • Innovative Trial Investigates Molecular Drivers of Triple-Negative Breast Cancer: A new clinical trial focusing on molecular biomarkers of triple-negative breast cancer (TNBC) is attempting to advance targeted therapy against the deadly disease.
  • Smac Mimetics Show Activity against Myelofibrosis: Not all cases of myelofibrosis respond well to ruxolitinib, the only drug approved for this disease. However, early studies indicate that a new class of drugs, Smac mimetics, can achieve a response in some patients with myelofibrosis.
  • Urothelial Cancer Subtypes Predict Treatment Response: Subtypes of urothelial cancer identified through gene expression profiling predict which patients are most likely to respond to neoadjuvant cisplatin-based chemotherapy, according to research from The University of Texas MD Anderson Cancer Center. These findings will pave the way for a more personalized approach to treatment for urothelial cancers, including difficult-to-treat muscle-invasive bladder cancer.
  • HOUSE CALL: How Smoking Affects Appearance-Tobacco smoke causes premature aging, other cosmetic problems

• 

  OncoLog, Volume 61, Number 10, October 2016

  Laura L. Russell, Joe Munch, Bryan Tutt, and Z Ahmed

  • Preventing Postoperative Urinary Tract Infections in Cancer Patients: Urinary tract infections (UTIs) increase morbidity, mortality and health care costs and prolong hospitalizations for patients who require urinary catheters-especially those who undergo long, complex surgeries or procedures to treat urological or gynecological cancers. To reduce the incidence of UTIs, clinicians at The University of Texas MD Anderson Cancer Center developed a quality improvement program for surgical patients at the institution.
  • Study Offers a Starting Point for Testing Immunotherapy in Rectal Cancer Patients with Deficient DNA Mismatch Repair: A recent study's findings provide a starting point for assessing the efficacy of immunotherapy in rectal cancer patients with deficient DNA mismatch repair (dMMR).
  • More than a Third of Colorectal Cancers in Patients Age 35 Years or Younger Are Hereditary, Study Finds: More than one-third of adolescents and young adults diagnosed with Colorectal cancer have hereditary disease, according to a study from The University of Texas MD Anderson Cancer Center.
  • Infusion of natural Killer Cells into the Brain Shows Promise against Medulloblastoma, Other Posterior Fossa Tumors: Medulloblastomas, the most common malignant brain tumors in children, are usually incurable if they recur. But a clinical trial of a novel therapy in which natural killer (NK) cells are infused directly into the brain is now enrolling young patients with recurrent medulloblastoma and other malignant tumors of the posterior fossa.
  • HOUSE CALL: Vitamin D and Cancer Prevention-Research is promising but still inconclusive.
  • Comprehensive Clinic Offers Expert Care for Hereditary Gastrointestinal Cancer Syndrome Patients, At-Risk Family Members: One valuable resource for patients with hereditary Gastrointestinal Cancer Syndrome is The University of Texas MD Anderson Cancer Center's Familial High-Risk Gastrointestinal Cancer Clinic.

• 

  OncoLog, Volume 61, Number 09, September 2016

  Jill Delsigne-Russell, Brandon C. Strubberg, and E Nielsen

  • Transport Oncophysics Could Guide Pancreatic Cancer Treatment: Pancreatic ductal adenocarcinomas respond poorly to standard treatments. Researchers at The University of Texas MD Anderson Cancer Center are applying the principles of physics to characterize the tumors, and these analyses could lead to individualized therapy.
  • Nivolumab Shows Potential in Treating Squamous Cell Carcinoma of the Anal Canal: Currently, there are no standard therapy options for patients with treatment-refractory metastatic squamous cell carcinoma of the anal canal (SCCA), but early results of a multi-institutional clinical trial (No. NCI9673) led by researchers at The University of Texas MD Anderson Cancer Center show that the immunotherapy drug nivolumab may be effective against the disease.
  • Lymphedema Screening Initiative for Breast Cancer Survivors Offers Early Diagnosis, Treatment: Lymphedema can be a debilitating side effect of breast cancer treatment. To diagnose and treat the condition early, when it may be reversible, a program at The University of Texas MD Anderson Cancer Center identifies and screens patients at high risk for lymphedema.
  • HOUSE CALL: Health and Fitness Apps- Software tools can help you achieve wellness.
  • USEFULRESOURCES: HPV-Associated Cancers Course

• 

  OncoLog, Volume 61, Number 08, August 2016

  Joe Munch, Bryan Tutt, and E Nielsen

  • Finding a Way Forward in Parathyroid Carcinoma: Among the rarest of the rare malignancies, parathyroid carcinoma poses myriad diagnostic and treatment challenges. Owing to its extreme rarity, very little is known about the mechanisms driving parathyroid carcinoma, let alone how to target them; and survival rates have not budged in decades. However researchers at The University of Texas MD Anderson Cancer Center are working to change this.
  • Studies Explore Screening for HPV-related Anal and Oropharyngeal Cancers: No consensus screening guidelines exist for human papillomavirus (HPV)-related cancers other than cervical cancer. As a step toward establishing such guidelines, studies under way or in the planning stages at The University of Texas MD Anderson Cancer Center will test various strategies for early detection of specific HPV-related cancers in populations believed to be at high risk.
  • HOUSE CALL: What You Should Know About Drug Advertisements-Prescription drug ads may not tell the whole story.

• 

  OncoLog, Volume 61, Number 07, July 2016

  Bryan Tutt, Sarah Bronson, and Laura Russell

  • Improving Rates of Vaccination after Hematopoietic Stem Cell Transplant: Patients who have undergone a hematopoietic stem cell transplant (HSCT) for a hematological cancer usually lose the immunity they had acquired through vaccination. Although guidelines exist for vaccinating immunocompromised transplant recipients, many patients go unvaccinated or do not complete the series of vaccinations. An ongoing initiative at The University of Texas MD Anderson Cancer Center is using a multipronged approach to improve rates of vaccination after HSCT.
  • Bone Loss Prevention in Patients with Cancer: Patients undergoing cancer treatment are at an increased risk of fractures because many cancer therapies tend to weaken the bones. Researchers at The University of Texas MD Anderson Cancer Center are investigating treatments to -prevent cancer-related bone loss and fractures as well as fracture-related sequelae such as immobility and blood clots.
  • INBRIEF: Experimental Drug LOXO-101 Shrinks Tumors with NTRK Fusions/ Local Consolidative Therapy for Oligometastatic Non-Small Cell Lung Cancer Triples Progression-Free Survival/ Immunotherapy Drug Nivolumab Reduces Tumor Burden in Patients with Metastatic Bladder Cancer
  • HOUSE CALL: Common Terms Used In Cancer Surgery- Cancer surgery is done in many ways for many reasons.
  • USEFULRESOURCES: Cancer Treatment Algorithms.

• 

  OncoLog, Volume 61, Number 06, June 2016

  Jill Deisigne, Joe Munch, Kathryn Hale, and B Strubberg

  • Proton Therapy Trials May Provide More Options for Patients with Non-Small Cell Lung Cancer: Proton therapy offers the potential to deliver a higher radiation dose to lung tumors and a lower dose to healthy tissues than does standard radiation therapy. However, the effectiveness of proton therapy has not yet been documented in clinical trials for patients with non-small cell lung cancer (NSCLC), the most common type of lung cancer. Two ongoing trials of proton therapy aim to demonstrate its effectiveness and may change the standard of care for NSCLC.
  • Innovative "Basket" Trial Shows Promise of BRAF Inhibition in Various Cancers: A groundbreaking clinical trial is demonstrating the promise of BRAF inhibition in multiple types of cancer and helping change the way researchers test treatments for cancers with actionable genetic aberrations.
  • Reducing the Likelihood of Second Primary Cancers in Cancer Survivors: Cancer survivors are at risk of not only cancer recurrence but also a second primary cancer. Their risk of a second cancer typically higher than the risk of a first cancer in the general population, but an individual survivor's risk varies by the type of initial cancer and other factors. To help cancer survivors manage the risk, the clinical services at The University of Texas MD Anderson Cancer Center include risk reduction and screening for second primary cancers.
  • HOUSE CALL: Types of Radiation Therapy and How They Are Used- Various techniques are used to treat cancer with radiation
  • USEFULRESOURCES: Breast Cancer Survivorship Course.

• 

  OncoLog, Volume 61, Number 05, May 2016

  Bryan Tutt and Katelyn Werner

  • Intratumoral Therapies Offer Novel Cancer Treatment Approach: Injecting cancer treatments such as vaccines and genetically modified bacteria and viruses directly into tumors may shrink or destroy the tumors and stimulate an immune response that attacks tumor cells. These treatments have shown promise in clinical trials, and newer trials are exploring whether such treatments can augment the effectiveness of immunotherapy in patients with metastatic or inoperable disease.
  • High-Risk Acute Lymphoblastic Leukemia Subtype Targeted in Upcoming Clinical Trial: Early T cell precursor acute lymphoblastic leukemia (ETP-ALL), an uncommon subtype of T cell acute lymphoblastic leukemia (T-ALL), carries a poor prognosis and low response rate to traditional chemotherapy drugs. But a clinical trial of a targeted agent that shows promise against ETP-ALL will soon be enrolling patients at The University of Texas MD Anderson Cancer Center.
  • HOUSE CALL: What Is Metastasis?-Understanding the spread of cancer
  • INBRIEF: New Staging System Proposed for HPV-Related Oropharyngeal Cancer

• 

  OncoLog, Volume 61, Number 04, April 2016

  Joe Munch, Bryan Tutt, and K Werner

  • Aggressive Multimodality Salvage Therapy for Locally Recurrent Rectal Cancer Offers Hope to Patients: For patients with locally recurrent rectal cancer, multimodality salvage therapy presents the only chance for a cure. Such therapy is offered at just a handful of specialized referral institutions, including The University of Texas MD Anderson Cancer Center.
  • Rapid Assessment, Clinical Trials Could Improve Outcomes for Anaplastic Thyroid Cancer Patients: Anaplastic thyroid cancer is extremely aggressive-only 20% of patients survive 1 year after their diagnosis-so patients require immediate assessment and treatment. A program at The University of Texas MD Anderson Cancer Center expedites the care of patients with this difficult-to-treat disease so that they can receive the best treatment possible, including access to clinical trials of promising new therapies.
  • HOUSE CALL: Skin Cancer Prevention-Avoiding ultraviolet rays from the sun and indoor tanning devices will help keep your skin healthy

• 

  OncoLog, Volume 61, Number 03, March 2016

  Bryan Tutt, Sarah Bronson, Jill Deisigne, and K Werner

  • Innovations Decrease Toxic Effects of Radiation Therapy for Mediastinal Tumors from Hematological Malignancies: Anterior mediastinal masses caused by lymphoma or leukemia can be difficult to treat because sensitive tissues in the area are vulnerable to damage from radiation therapy. To treat these tumors while sparing healthy tissue, radiation oncologists at The University of Texas MD Anderson Cancer Center use a combination of advanced technologies and new techniques.
  • Transoral Robotic Surgery Enables Less Toxic Treatment of Early Throat Cancers: For decades, many patients with hard-to-reach throat cancers received high-dose radiation and chemotherapy, with their often severe toxic effects, because conventional surgery was highly invasive and disfiguring. Now that minimally invasive robotic surgery can be used to resect cancers of the tongue base and tonsils without causing disfigurement, researchers at The University of Texas MD Anderson Cancer Center are learning how this treatment can help minimize the use of radiation and chemotherapy and improve patients' quality of life.
  • Implantable Devices Monitor for Cardiac Events in Cancer Survivors and Patients on Chemotherapy: Cancer survivors are more likely to die from heart disease than cancer, and therefore patients must be closely monitored for heart problems during and after cancer treatment. Such surveillance can be done continuously with new implantable cardia monitoring devices.
  • HOUSE CALL: Colorectal Cancer Screening-Regular screening is key for fighting and preventing colon and rectal cancers
  • USEFULRESOURCES: Clinical Trials Information

• 

  OncoLog, Volume 61, Number 02, February 2016

  Joe Munch, Bryan Tutt, and C Graber

  • Overcoming Challenges in Cutaneous T Cell Lymphomas: Cutaneous T Cell lymphomas (CTCLs) not only are largely incurable but also make patients miserable with itching, burning skin and unsightly lesions. Because CTCL can resemble various benign skin conditions, many patients are diagnosed at an advanced and difficult-to-treat stage. But ongoing clinical trials may offer patients with CTCL improved treatments and better quality of life.
  • Swallowing Therapy Improves Function and Quality of Life for Patients with Head and Neck Cancer: In patients with head and neck cancer, loss of swallowing function may result from radiation therapy, surgery, or the cancer itself and lead to poor health and reduced quality of life. At The University of Texas MD Anderson Cancer Center, individualized swallowing therapy programs directed by speech pathologists are helping patients maintain or recover their swallowing function during and after treatment.
  • HOUSE CALL: Common Cancer Terms-Clearly understanding medical terms helps patients, caregivers

• 

  OncoLog, Volume 61, Number 01, January 2016

  Sarah Bronson, Bryan Tutt, and Bryan Tutt

  • Proactive Management of Li-Fraumeni Syndrome Benefits Patients: Li-Fraumeni syndromes a hereditary disorder that confers an extremely high likelihood of developing cancer on affected individuals.
  • Clinical Trial Tests High-Dose Radiation Therapy for Limited Stage Small Cell Lung Cancer: Small cell lung cancer carries a poor prognosis, even for patients without metastatic disease. But a phase III trial of high-dose daily or accelerated twice-daily thoracic radiation therapy for limited stage small cell kung cancer may lead to longer survival.
  • Reducing Complications and Hospital Readmissions after Liver Surgery: Hepatectomy carries a risk of complications that can lead to hospital readmission and even death. Even as modern surgical techniques make liver surgery safer and less invasive, a series of initiatives at The University of Texas MD Anderson Cancer Center has resulted in reduced rates of complications and hospital readmission for patients who undergo hepatectomy.
  • HOUSE CALL: When Should Women Begin Breast cancer Screening?-Guidelines vary, but annual screening is best for most women 40 years and older.
  • USEFULRESOURCES: Cancer Screening and Risk reduction Algorithms.

• 

  OncoLog, Volume 60, Number 11 - 12, November - December 2015

  Joe Munch, Bryan Tutt, and C. Graber

  • Multidisciplinary Treatment Maximizes Outcomes for malignant Tumors of the Anterior Skull Base: Malignant tumors of the anterior skull base occur in a delicate area but often need aggressive treatment. Determining the best course of therapy for patients with these tumors takes a multidisciplinary effort.
  • Management of Eyelid and Conjunctival Tumors with Preservation of Slight, Function and Cosmesis: Tumors of the eyelid and extent of disease, and which treatments, if any, are needed after surgical excision depends on several factors, including the potential for metastasis.
  • HOUSE CALL: "Other" Health Risks from Smoking-Besides cancer, tobacco causes many diseases.

• 

  OncoLog, Volume 60, Number 10, October 2015

  Joe Munch, Bryan Tutt, Jill Deisigne, and K. Nair

  • New Targeted Therapy Offers Hope to Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm, Related Diseases: The treatment of common hematological malignancies is based on reams of study data and years of physician experience with the diseases. But such information is often limited for rare, little-researched blood cancers like blastic plasmacytoid dendritic cell neoplasm (BPDCN). This situation may soon change, thanks to the discovery of a new molecular target, which has led to a spate of innovative treatment approaches and the first dedicated clinical trials for this uncommon malignancy.
  • Laparoscopic Free Omental Lymphatic Flap Transfers Offer a Powerful Alternative for Lymphedema Treatment: Armed with new laparoscopic and microsurgical techniques, surgeons are revisiting the use of omental flaps to safely and effectively treat lymphedema in breast cancer patients.
  • Naproxen Shows Potential for Chemoprevention in Patients with Lynch Syndrome: People with Lynch syndrome face a high risk of colorectal cancer. But researchers think that reducing this risk may be as easy as taking a daily over-the-counter pill.
  • HOUSE CALL: Preparing for a Hospital Stay- What to bring-and what to leave at home-to make your stay more pleasant
  • INBRIEF: Beta-Blockers May Prolong Ovarian Cancer Patients' Survival

• 

  OncoLog, Volume 60, Number 09, September 2015

  Sarah Bronson, Bryan Tutt, and K. Nair

  • Enhanced Surgical Recovery Programs Improve Perioperative Outcomes for Cancer Patients: For patients undergoing cancer surgery, potential complications and long recovery times can delay the delivery of additional life-saving therapy. To improve patients' perioperative outcomes and clear the way for timely administration of additional therapies, several surgical teams at The University of Texas MD Anderson Cancer Center gave begun using enhanced surgical recovery programs (ESRPs).
  • New Treatments for Respiratory Viruses in Immunocompromised Patients: Viral respiratory infections are a major concern for immunocompromised patients, in whom such infections are difficult to treat and can lead to pneumonia and even death. Although few treatment options for such infections have been available, clinical trials of promising new therapies are now enrolling immunocompromised patients with two common respiratory viruses: respiratory syncytial virus (RSV) and parainfluenza virus (PIV).
  • INBRIEF: 14-3-2Q Protein Prevents Tumor-Promoting Metabolic Reprogramming/miR-506 MicroRNA May Help Overcome Chemotherapy Resistance in Ovarian Cancer
  • HOUSE CALL: Types of Drugs Used to Treat Cancer: Cytotoxic, targeted, and immunotherapy drugs have different functions and side effects

• 

  OncoLog, Volume 60, Number 08, August 2015

  Stephanie Deming, Bryan Tutt, and K. Nair

  • New Gene Therapy for Bladder Cancer Shows Promise: A gene therapy that stimulates interferon production within the body may prove to be effective against high-risk, early-stage bladder cancer when standard treatment fails.
  • Vaccine Helps T Cells Target Sarcomas, Melanomas and other Tumors: A vaccine that delivers an antigen to dendritic cells, in turn activating killer T cells that can target specific cancers, is the subject of two ongoing clinical trials,
  • INBRIEF: Glypican-1 Shows Promise as a Biomarker for Pancreatic Cancer/Stereotactic Ablative Radiation Therapy for Stage I Non-Small Cell Lung Cancer May Offer Survival Benefit
  • HOUSE CALL: Prostate Cancer Screening-Who should get screened and when

• 

  OncoLog, Volume 60, Number 07, July 2015

  Kathryn L. Hale, Bryan Tutt, and K. Stuyck

  • Emergency Care for Cancer Patients: Medical problems that may seem routine in patients without cancer often mean something different or have a different cause in cancer patients and may be much more serious, requiring urgent treatment. Managing these problems promptly and effectively is a challenge faced by all cancer centers.
  • Immunotherapy Trials Offer Hope to Patients with High-Risk or Metastatic Cancer: Although the cure rate for the breast cancer has risen steadily in recent decades, recurrent or metastatic disease remains difficult to control. To fight metastatic breast cancer and forestall the recurrence of high-risk primary disease, researchers at The University of Texas MD Anderson Cancer Center are using various techniques to boost the body's immune system. Clinical trials of many of these therapies are already under way.
  • HOUSE CALL: Hospital Patient Advocates Provide Support-Advocates serve as liaisons between hospitals and patients

• 

  OncoLog, Volume 60, Number 06, June 2015

  Bryan Tutt, Joe Munch, and U. Arizor

  • New Breast Imaging Modalities Show promise for Cancer Screening and Staging: New technology to supplement digital mammography may improve breast cancer screening and diagnosis. Although some of these new imaging modalities are still under development, others are already in clinical use as adjuncts to mammography for breast cancer screening and staging.
  • Addressing Sexual Dysfunction in Cancer Survivors: Cancer treatments carry a host of side effects that can affect patients' ability to have and enjoy sex. The sexual dysfunction arising from these side effects, which include functional changes, can often be addressed, but uncovering sexual dysfunction can prove challenging.
  • HOUSE CALL: Dental Hygiene and Care Before, During, and After Cancer Treatment-Measures to protect oral health
  • INBRIEF: New Assay Could Lead to Earlier Ovarian Cancer Detection

• 

  OncoLog, Volume 60, Number 05, May 2015

  Sarah Bronson, Bryan Tutt, and U. Arizor

  • Algorithm for Treating Advanced Ovarian Cancer Increases Complete Resection Rate: Most ovarian cancers have spread beyond the ovary by the time they are diagnosed, and they often recur even after responding to primary treatment. Researchers at The University of Texas MD Anderson Cancer Center aim to improve patient outcomes by changing the standard approach to newly diagnosed advanced ovarian cancer.
  • Clinical Trials Explore Systemic Treatments for Brain Metastases from Breast Cancer: Brain metastases from breast cancer are difficult to treat because many of the systemic drugs that are effective against breast cancer cannot cross the blood-brain barrier. But researchers at The University of Texas MD Anderson Cancer Center are working to overcome this challenge and are testing new systemic treatments for breast cancer brain metastases in three clinical trials.
  • HOUSE CALL: Tips for Communicating with Health Care Providers-Preparing for appointments can help you get the answers you need
  • INBRIEF: Sentinel Lymph Node Mapping Identifies Node-Positive, High-Risk Endometrial Cancer

• 

  OncoLog, Volume 60, Number 04, April 2015

  Jill Deisigne, Joe Munch, Bryan Tutt, and Sarah Bronson

  • Multidisciplinary Globe-Sparing Treatment for Lacrimal Gland Carcinoma Preserves Vision and Minimizes Morbidity: Until recently, the treatment of lacrimal gland carcinoma almost always required removal of the eye. But for some patients with these tumors, globe-sparing surgery followed by radiation therapy can preserve vision and decrease ocular morbidity and facial disfigurement.
  • Novel Trial Design Streamlines Development of Breast Cancer Therapies: Developing a cancer-fighting drug can take around a billion dollars and a dozen or more years. Even then, fail in clinical trials. To identify effective cancer therapies more quickly and efficiently, researchers have tuned to an innovative clinical model in which multiple treatments are investigated simultaneously and the study design is adapted as patient data accrue.
  • Targeted Therapy for High-Risk Melanoma May Forestall Recurrence: Although targeted agents have been approved for the treatment of metastatic melanoma, such agents typically are not used in patients with earlier-stage, respectable disease who have a high risk for recurrence. But a clinical trial of targeted therapy before and after surgery aims to prolong recurrence-free survival for patients with respectable high-risk melanoma.
  • HOUSE CALL: Interpreting Health News-Common mistakes in medical reporting

• 

  OncoLog, Volume 60, Number 03, March 2015

  Bryan Tutt, Kathryn L. Hale, and K. Stuyck

  • Small Cell Lung Cancer Studies May Increase Treatment Options: Despite advances in treating many cancers, the standard treatment of small cell lung cancer has remained unchanged for decades. But researchers at The University of Texas MD Anderson Cancer Center are exploring several new approaches to treat small cell lung cancer.
  • Improved Maintenance Therapy Promotes Myeloma patients' Quality of Life After Stem Cell Transplantation: High-dose chemotherapy followed by autologous stem cell transplantation can prolong survival for patients with multiple myeloma. However, patients remain at a high risk of relapse even after transplantation. Maintenance therapy can extend remission in these patients, and clinical trials at The University of Texas MD Anderson Cancer Center are exploring new maintenance regimens to further improve patients' outcomes.
  • Primary Tumor Resection may Be Overused in Patients with Metastatic Colon Cancer: Primary tumor resection may be overused in patients with newly diagnosed stage IV colorectal cancer, according to the findings of a new study from The University of Texas MD Anderson Cancer Center.
  • HOUSE CALL: How Hospital Chaplains Help-Chaplains help patients and families deal with emotional and spiritual concerns.

• 

  OncoLog, Volume 60, Number 02, February 2015

  Sarah Bronson, Bryan Tutt, and N. Danckers

  • Natural Killer Cell Therapy May Augment Treatment of Hematological Cancers: Tough cancer treatments can severely weaken the body's natural ability to attack cancer cells. To improve immune recovery and function in patients who have undergone these treatments, especially those who may later receive a stem cell transplant, researchers are turning to natural killer cells that have been expanded in the laboratory.
  • Concurrent Treatment of HIV and Cancer Improves Survival Outcomes: Concurrent HIV and cancer present special challenges in the clinic, regardless of which disease is diagnosed first. The simultaneous treatment of HIV and cancer is complicated by patients' weakened immune systems, the lack of routine HIV screening, and interactions between drugs. Infectious disease specialists at The University of Texas MD Anderson Cancer Center routinely treat HIV in cancer patients and are discovering ways to overcome these challenges.
  • HOUSE CALL: Facts About Radiation-Radiation exposure comes from many sources
  • INBRIEF: Sleeping Beauty Gene Therapy Shows Promise Against B Cell Malignancies

• 

  OncoLog, Volume 60, Number 01, January 2015

  Bryan Tutt, Markeda Wade, Bryan Tutt, and N. Danckers

  • Simultaneous Resection of Liver and Lung Metastases from Colorectal Cancer Eliminates Need for Second Surgery: Patients with colorectal cancer metastases to the liver and one or both lungs often face the unwelcome prospect of two operations and two recovery periods. But a novel surgical approach enables the liver and lung lesion resections to be performed during the same operation.
  • Some Breast Cancer Patients May Benefit from Shorter Course of Whole-Breast Irradiation: A shorter course of radiation therapy at higher doses per fraction than the standard regimen could reduce side effects and improve quality of life for some patients with breast cancer.
  • IMPACT2 Study Tests Benefits of Personalized Cancer Treatment based on Molecular Profiling: Molecular profiling has the potential to revolutionize cancer medicine by helping clinicians select treatments based on the genomic characteristics of each patient's tumor. But for most types of cancer, this potential has yet to be verified by a randomized clinical study-in which treatment selection based on tumor molecular profiling-is now enrolling patients with metastatic solid tumors at The University of Texas MD Anderson Cancer Center.
  • HOUSE CALL: Telling Your Child About Your Cancer-Open, honest communication helps children cope

• 

  OncoLog, Volume 59, Number 11-12, November-December 2014

  Bryan Tutt, Sunita Patterson, and S. Moreau

  • Striving to Improve Treatments for Uveal Melanoma: Although primary uveal melanoma can be effectively treated with radiation or surgery, patients with metastatic disease-or those at high risk for metastases-have few proven options. But specialists in medical oncology, radiation oncology, ophthalmology, surgery, and traditional research are working to improve those options
  • Beyond Diabetes: Metformin May Have Broad Utility in Cancer: Metformin, an inexpensive drug that has been prescribed for diabetes for decades, may also be useful in preventing or treating several types of cancer
  • HOUSE CALL: Smoking Cessation-Medications help smokers quit
  • INBRIEF: Vaccine Explored to Reduce Risk of HER2-Positive Breast Cancer Recurrence

• 

  OncoLog, Volume 59, Number 10, October 2014

  Sarah Bronson, Kathryn L. Hale, Roberto Molar-Candanosa, and K. Stuyck

  • New Drugs for Myeloproliferative Neoplasms Ease Suffering and Extend Life: A new class of drugs has redefined treatment for patients with myeloproliferative neoplasms by easing their symptom burden while extending their lives
  • Neoadjuvant Targeted Therapy May Offer Multiple Benefits for Patients with Locally Advanced Renal Cancer: Despite definitive treatment with nephrectomy, locally advanced renal cancer recurs in 20%-30% of patients, substantially reducing their chance for long-term survival. To prevent such recurrences and prolong survival, urologic oncologists are studying the integration of targeted molecular therapies with surgical treatments
  • New Combination Therapy Offers Potential to Cure FLT3-ITD Acute Myelogenous Leukemia: A new combination therapy using plerixafor, granulocyte colony-stimulating factor (G-CSF), and sorafenib may lead to lasting remissions-and possibly even a cure-for patients with acute myelogenous leukemia (AML) carrying the internal tandem duplication (ITD) mutation in the Fms-like tyrosine kinase 3 (FLT3) gene
  • HOUSE CALL: Symptoms of Cancer-Lasting symptoms can mean cancer or other diseases

• 

  OncoLog, Volume 59, Number 09, September 2014

  Stephanie Deming, Bryan Tutt, Joe Munch, and Jill Deisigne

  • Biomarker-Driven Clinical Trials may Improve Personalized Treatment for Patients With Lung Cancer: Innovative clinical trials that assign patients to treatment arms based on tumor biomarkers could lead to increase treatment options for patients with lung cancer
  • New Antibody-Chemotherapy Combinations Show Promise Against Acute Lymphoblastic Leukemia: Two investigational agents-inotuzumab and ofatumumab-shows promise when combined with cytotoxic chemotherapy drugs for the treatment of acute lymphoblastic leukemia (ALL) in adults
  • Deep Inspiration Breath Hold Protects Against Radiation-Induced Cardiotoxicity in Patients With Left-Sided Breast cancers: Patients with lest-sided breast cancers have an increased risk of heart damage from adjuvant radiation therapy given after lumpectomy or mastectomy
  • HOUSE CALL: Books Can Help Patients Deal With Cancer-Fiction and nonfiction can provide encouragement and education
  • INBRIEF: Large-Scale Molecular Data Analysis Yields Multiple Benefits

• 

  OncoLog, Volume 59, Number 08, August 2014

  Kathryn L. Hale, Bryan Tutt, Sunita Patterson, and R. Molar-Candanosa

  • Immune Checkpoint Inhibitors Show Promise Against Metastatic Renal Cell Carcinoma, Other Difficult-to-Treat Cancers: A decade ago, oncologists had little to offer most patients with metastatic renal cell carcinoma (RCC). However, a breakthrough discovery that has already changed the treatment of metastatic melanoma is showing promise against other metastatic cancers-including metastatic RCC-and giving patients new hope for long-term survival
  • Clinical Study Offers Definitive Local Treatment of Bone Metastases from Breast Cancer: Metastatic breast cancer carries a poor prognosis, and most systemic treatments for metastatic disease aim to slow its progression rather than to cure it. In a select group of patients, however, systemic treatment combined with definitive local treatment of the metastatic tumors can offer long-term progression-free survival-and perhaps a cure
  • New Scoring System for Hepatic Reserve Could Help in Planning Treatment for Hepatocellular Carcinoma: An innovative test for evaluating hepatic reserve may improve clinicians' ability to predict prognosis and select appropriate therapy for patients with hepatocellular carcinoma (HCC)
  • INBRIEF: Needle Biopsy Underused in Breast Cancer Diagnosis
  • HOUSE CALL: Managing Stress After cancer Treatment- Communication helps cancer survivors cope with stress

• 

  OncoLog, Volume 59, Number 07, July 2014

  Sarah Bronson, Joe Munch, Bryan Tutt, and K. Stuyck

  • Side Effects of Targeted Molecular Agents Vary According to Mechanism of Action: The main side effects of cytotoxic chemotherapy are notorious. But the side effects of newer, targeted molecular agents are less well known, so patients receiving such drugs may not know what to expect and may require additional guidance from physicians
  • INBRIEF: Study Finds Less Frequent Bisphosphonate Treatment Equivalent to Standard Regimen
  • RAS Mutation Status May predict Outcomes After Surgery for Colorectal Cancer Liver Metastases
  • HPV Test Does Not Replace Pap Test for Cervical cancer Screening: The recent approval of a human papillomavirus (HPV) test for cervical cancer screening has created confusion within the medical community about appropriate screening guidelines
  • HOUSE CALL: Advance Directives Make Patient's Wishes Known- Types of advance directives and their functions

• 

  OncoLog, Volume 59, Number 06, June 2014

  Jill Deisigne, Luanne Jorewicz, and K. Stuyck

  • New Agents Hold Promise for Patients With Advanced Thyroid Cancer: New agents are expanding treatment options for patients with advanced thyroid cancer-not only the papillary variant but also the less common medullary and differentiated variants of the disease
  • Surgical Options for Lymphedema: Lymphedema of the extremities, whether from cancer treatment or other causes, typically is not curable. But advances in surgical techniques are reducing or eliminating symptoms for many patients
  • INBRIEF: Intensity-Modulated Radiation Therapy Improves Survival in Head and Neck Cancer Patients/ Research Findings Could Lead to Blood Test for Cancer-Related Gene Defects/ Tumor-Suppressing Protein May Help Predict Survival in Some Breast Cancer Patients
  • HOUSE CALL: Sleep Problems in Cancer Patients-Sleep disorders can be managed

• 

  OncoLog, Volume 59, Number 05, May 2014

  Bryan Tutt, Therese Bevers, and Zach Bohannan

  • New Treatments may Improve Outcomes for AL Amyloidosis Patients: AL amyloidosis-a rare, potentially fatal disease-has no approved treatments. The ''standard'' treatments are prescribed off-label, and few clinical trials have compared their effectiveness
  • Dialog: Screening Mammography Reduces Breast Cancer-Related deaths
  • 'Sleeping Beauty'' Technique Modifies T Cells to Treat B Cell Malignancies: A novel technique that helps the patient's own immune system find and destroy cancer cells could extend remission times for patients with B cell lymphomas and leukemias
  • INBRIEF: Analysis Suggests Need to Revise Low-Grade Glioma Classification, Treatment/Combination of Antiangiogenic Drugs Shows Activity Against Solid Tumors/ Computed Tomography Predicts Chemotherapy Response in Pancreatic Cancer
  • Screening Mammography for Breast Cancer Saves Lives: MD Anderson recommends most women being screening mammography at age 40

• 

  OncoLog, Volume 59, Number 04, April 2014

  Zach Bohannan, Joe Munch, and J. Delsigne

  • New fat Grafting Technique Improves Aesthetic Outcomes Following Head and Neck Reconstructive Surgery: A new gat grafting technique is enabling reconstructive surgeons to maximize aesthetic outcomes following major reconstruction for head and neck cancer treatment-related defects
  • INBRIEF: Invasive Bladder Cancer Subtypes Resemble Breast Cancer Subtypes
  • New Kinase Inhibitors Hold Promise for Chronic Lymphocytic Leukemia, Other B-Cell Malignancies: New targeted therapies against chronic lymphocytic leukemia (CLL) are eliciting overall response rates similar to those achieved using standard chemoimmunotherapy but with fewer toxic effects
  • HOUSE CALL: Animal-Assisted Therapy- Interacting with pets helps recovery

• 

  OncoLog, Volume 59, Number 03, March 2014

  Bryan Tutt, Joe Munch, and K. Stuyck

  • Expanding the Use of Laparoscopic Liver Resection: Minimally invasive surgical resection of liver tumors once was used only in select patients with easily accessible lesions located in the anterior of the liver. However, recent improvements in surgical techniques and the use of preoperative imaging have made laparoscopic approaches possible for even compels liver resection
  • Physicians Refining Lung Cancer Screening Program: Lung cancer screening with low-dose computed tomography (CT) has been shown to reduce the rate of lung cancer-specific mortality in people at high risk for the disease
  • Should the Primary Tumor Be Treated in Patients With Metastatic Prostate Cancer?: Researchers at The University of Texas MD Anderson Cancer Center hope to determine whether treating the primary tumor has any oncologic benefit in patients with metastatic prostate cancer
  • HOUSE CALL: Vaccines That Prevent Cancer- Hepatitis B and HPV vaccines protect against cancer-causing viruses

• 

  OncoLog, Volume 59, Number 02, February 2014

  Sarah Bronson, Kathryn L. Hale, Bryan Tutt, and M. Yeoman

  • New Approaches Revolutionize the Treatment of Advanced Melanoma: Recent breakthroughs in immunotherapy and targeted therapy have improved outcomes for patients with advanced melanoma
  • Comprehensive Tobacco Treatment Approach Helps Patients Quit on Their Terms: Kicking a tobacco habit is a formidable task. Quitting tobacco after a diagnosis of cancer, can be even more difficult
  • Targeted Drug Shows Promise Against Advanced Breast Cancer: Adding the experimental kinase inhibitor palbociclib to standard hormonal therapy may delay disease progression in patients with advanced breast cancer that is estrogen receptor (ER) positive and human epidermal growth factor receptor 2 (HER@) negative
  • HOUSE CALL: Avoiding Food-Drug Interactions: Some foods and medicines don’t mix
  • INBRIEF: PKM2 Identified as Potential Prognostic Marker for Glioblastoma

• 

  OncoLog, Volume 59, Number 01, January 2014

  Joe Munch, Jill Delsigne, and M. Yeoman

  • Addressing Fertility Issues in Cancer Patients: For some newly diagnosed cancer patients, whether they will be able to have children after treatment is the furthest question from their minds-until the risks of therapy bring it front-and-center
  • INBRIEF: Intensity-Modulated Proton Therapy May Reduce Side Effects of Oropharyngeal Carcinoma Treatment
  • Medical Advances Improve Bile Duct Cancer Treatment: Cholangiocarcinoma, the most common bile duct cancer, is a clinically silent disease in its early stages; patients usually present with advanced disease, which carries a poor prognosis
  • HOUSE CALL: Weight Loss Tips for Breast Cancer Survivors-Losing excess weight has multiple benefits

• 

  OncoLog, Volume 58, Number 11-12, November - December 2013

  Amelia Scholtz, Bryan Tutt, Luanne Jorewicz, and K Stuyck

  • Paget Disease of the Breast: A Rare, Often Misdiagnosed Malignancy: A small, scaling rash around the nipple may not be just another case of eczema or dermatitis. Paget disease of the breast, a rare malignancy, is often mistaken for a benign dermatological condition. But Paget disease typically indicates underlying ductal carcinoma in situ or invasive breast cancer
  • New Partial-Breast Radiation Therapy Regimen Uses Protons: Whole-or partial-breast radiation therapy can reduce a patient's chance of brest cancer recurrence after lumpectomy, but this benefit must be weighed against the risk of damage to healthy tissue
  • Managing Dental Complications in Patients with Head and Neck Cancer: Dental complications in patients with head and neck cancer can be serious or even life-threatening if not managed effectively
  • INBRIEF: NF-kB May Be Linked to Glioblastoma Treatment Resistance
  • HOUSE CALL: Health Benefits of Quitting Smoking-It's never too late to quit, but sooner is better

• 

  OncoLog, Volume 58, Number 10, October 2013

  Bryan Tutt, Sunni Hosemann, and C. Wilcox

  • Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer May replace Axillary Dissection for Some Patients: Sentinel lymph node dissection has become a standard staging tool for breast cancer patients with no clinical eveidence of disease in the lymph nodes
  • INBRIEF: miR-200 MicroRNAs Slow Tumor Growth
  • Compass: Resectable or Borderline Resectable Pancreatic Adenocarcinoma: Initial Treatment Options-Neoadjuvent chemoradiation may benefit patients with resectable disease
  • HOUSE CALL: Hereditary Cancers: Genetic screening can give valuable information

• 

  OncoLog, Volume 58, Number 09, September 2013

  Jill Deisigne and Markeda Wade

  • Advances in Neuroimaging Help Unveil the Mechanisms of Chemobrain: Chemobrain, a catchall term for the cognitive dysfunction and neurophysiological changes produced bt chemotherapy toxicity, is an important quality-of-life issue for cancer survivors
  • Opioid Rotation Can Improve Pain Control and Reduce Neurotoxicity for Cancer Patients: Opioids are a main stay in the relief of pain-especially the chronic cancer-related pain often encountered in the palliative care setting. However, extended opioid use can result in tolerance, dependence, and opioid-induced neurotoxicity
  • INBRIEF: Researchers Identity Inhibitor of Cancer-Promoting Protein SKp2/ Change in CA-125 Level Over Time Shows Promise for Ovarian cancer Screening
  • HOUSE CALL: Myths and Facts About Pain and Cancer-Patients have options for pain treatment

• 

  OncoLog, Volume 58, Number 08, August 2013

  Bryan Tutt and Sarah Bronson

  • Specialized Care Improves Lives of patients With Head and Neck Lymphedema: A unique program is producing dramatic results for patients with head and neck lymphedema, a side effect of cancer treatment that can interfere with patient's ability to speak, swallow, or breath
  • Targeted Cancer Therapies May Help Overcome Resistance to Radiation Therapy: Some cancer cells are resilient enough to withstand and recover from the damage to their DNA caused by radiation therapy. But recent studies have shown that adding molecularly targeted agents to radiation therapy can prevent the repair of this radiation-induced damage and therapy improve the treatment response of patients with certain cancers
  • INBRIEF: New Test Helps Identify Glioblatoma Patients Who Could Benefit from Bevacizumab
  • HOUSE CALL: Depression in Cancer Patients: Managing depression improves quality of life and possibly cancer treatment outcomes

• 

  OncoLog, Volume 58, Number 07, July 2013

  Zach Bohannan and Sunni Hosemann

  • Treating Diabetes in Cancer Patients: Type 2 diabetes is a serious health concern for any patient-but when the patient also has cancer, diabetes may interfere with potentially life-saving cancer treatment
  • INBRIEF: MET Protein May Serve as a Biomaker for a Treatment-Resistant Colorectal Cancer Subtype
  • Compass: Penile Cancer- Although curable, localized or regional squamous cell carcinoma of the penis present treatment dilemmas
  • HOUSE CALL: Stand Up for Your Health- Prolonged sitting may increase your risk for cancer and other disease

• 

  OncoLog, Volume 58, Number 06, June 2013

  Joe Munch, Amelia Scholtz, and Luanne Jorewicz

  • Addressing Emerging Survivorship Issues in Glioblastoma Patients: An increasing number of glioblastoma patients are becoming '' long-term'' survivors-living 3 or more years after diagnosis
  • Prediction Tool Helps Determine Whether Older Breast Cancer Patients will benefit from Radiation: A statistical tool is now available to predict the likely individual benefit of radiation therapy for older women who have undergone breast-conserving surgery for breast cancer
  • Sequential Multidrug Regiman May Offer an Alternative to Standard Cisplatin-Based Therapy for Urothelial Cancer: Cisplatin-based chemotherapy is the standard neoadjuvant treatment for high-risk, surgically resectable, invasive urothelial cancer. But some patients are not good candidates for this chemotherapy owing to certain disease characteristics or comorbidities
  • HOUSE CALL: Cancer Blogs Provide Insight from Patients-Bloggers offer information and inspiration to others affected by cancer

• 

  OncoLog, Volume 58, Number 05, May 2013

  Jill Deisigne and Bryan Tutt

  • Robotic Surgery Makes Tissue Harvest for Breast Reconstruction Less Invasive: A new minimally invasive robotic procedure enables surgeons to harvest latissimus dorsi muscle flaps for breast reconstruction with less scarring and discomfort than traditional techniques
  • Diagnosis and Treatment of Invasive Fungal Infections in patients with Hematological Malingnancies: Invasive fungal infections are important causes of morbidity and death for patients with hematological malignancies. Although much progress has been made in the management of opportunistic fungal infections, their diagnosis and treatment remain a challenge
  • INBRIEF: Beta-Blocker Use Associated With Higher Survival Rates in Lung Cancer Patients Receiving Radiation Therapy/ Selumetinib Shows Promise for Patients With Recurrent Low-Grade Ovarian Cancer
  • HOUSE CALL: Myths and facts About Skin Cancer-What you don't know could hurt you

• 

  OncoLog, Volume 58, Number 04, April 2013

  Kathryn L. Hale and Sunni Hosemann

  • Preventing and Treating Graft-Versus-Host Disease After Stem Cell Transplantation: Each year, thousands of patients with hematologic malignancies undergo allogeneic (donor) stem cell transplantation (SCT), which offers a chance at cure. Graft-versus-host disease (GHVD) is a potentially deadly complication of this therapy and occurs in 25%-60% of patients. However, clinicians and researchers are continually working to reduce the rate of GVHD occurrance and improve patient outcomes
  • Compass: Breast cancer Risk Reduction: Women at increased risk have multiple options
  • HOUSE CALL: Benefits of In-Person Support Groups- Face-to-face contact helps people cope with chronic illness

• 

  OncoLog, Volume 58, Number 03, March 2013

  Sarah Bronson, Zach Bohannan, and Bryan Tutt

  • Advances in Pulmonary Medicine Facilitate Cancer Diagnosis, Treatment: The lungs present unique challenges in cancer diagnosis and treatment-navigating a maze of bronchi to find and sample tissue that will lead to an accurate diagnosis of lung cancer, for example, or deciding whether to proceed with treatment for cancer in the presence of concomitant lung disease
  • New Drugs Increase Treatment Options for Patients with Imatinib-Resistant Chronic Myeloid Leukemia: In the past year, several new targeted drugs have been approved as second-line treatments for imatinib-resistant chronic myeloid leukemia (CML). These drugs include the second-generation tyrosine kinase inhibitor bosutinib and the third-generation tyrosine kinase inhibitor ponatinib, which may change the standard of care for CML
  • Program Offers Physicians Courses on Treating Cancer Patients and Survivors: A series of courses available online enables physicians at The University of Texas MD Anderson Cancer Center to share with a global medical audience lessons learned from treating a high volume of patients at a tertiary cancer center
  • HOUSE CALL: Managing the Financial Burden of Long-Term Illness-Help is available for many patients

• 

  OncoLog, Volume 58, Number 02, February 2013

  Bryan Tutt and Jill Delsigne

  • Chronic Viral Hepatitis in Cancer Patients Requires Personalized Management: Chronic viral hepatitis is life-threatening for many patients but curable or manageable for others. But in patients who have both viral hepatitis and cancer, cancer treatment may exacerbate the viral infection and lead to other complications, such as liver failure or even death
  • Managing Sleep Disorders in Cancer Patients: Quality sleep is essential to healing, to proper immune function, and even to mental health. Conversely, lack of sleep has been associated with depression, anxiety, and decreased cognitive function. In cancer patients, poor sleep reduces quality of life; nevertheless, most cancer patients do not mention sleep problems unless explicitly asked.
  • INBRIEF: Ex Vivo Umbilical Cord Blood Expansion Hastens Stem cell Engraftment in Transplant Recipients/Ibrutinib Shows Promise for Mantle Cell Lymphoma Treatment
  • HOUSE CALL: Finding Information About Alternative Medicine: How to choose credible sources and avoid pitfalls

• 

  OncoLog, Volume 58, Number 01, January 2013

  Joe Munch and Sunni Hosemann

  • Emerging Vaccines Take Aim at Preventing Recurrent Breast Cancer: Myriad advances have been made in the treatment of breast cancer, and cures are achieved in many patients. However, there are still patients whose cancer recurs, and most of these patients will die of their disease. This indicates a need for other therapies that can be used to prevent recurrent disease. One potential option is breast cancer vaccines.
  • Compass: Hepatocellular Carcinoma: Concomitant liver disease affects treatment options
  • HOUSE CALL: Music Therapy-Music therapists help cancer patients manage stress and side effects

• 

  OncoLog, Volume 57, Number 11-12, November - December 2012

  Kathryn L. Hale, Amelia Scholtz, and Luanne Jorewicz

  • Research Explores Link Between Thrombocytosis and Cancer: High platelet counts can be an early indicator of cancer, In fact, about one-third of women with ovarian cancer have an abnormally high platelet count at the time of diagnosis. This paraneoplastic thrombocytosis is also seen in patients with cancers of the gastrointestinal tract, lung or breast
  • Wide Range of Cancer Treatments May Produce Ocular Complications: Although most ocular side effects of cancer treatment may be transient and reversible, regular ophthalmic examinations and effective doctor-patient communication can help cancer patients avoid permanent damage
  • New Software May Provide a Standardized Reporting System for Diagnostic Radiologists: Radiologists today still report the results of patient imaging examinations in a manner similar to that which has been used for more than 100 years-by providing narrative descriptions that vary in content and clarity
  • HOUSE CALL: Smoking-Related Cancers-Cancer risks from tobacco are not limited to the lungs-Most people are aware that smoking is the most common cause of lung cancer, but fewer may know that smoking causes many other types of cancer as well
  • INBRIEF: Biological Therapies for Rheumatoid Arthritis Not Associated With Increased Cancer Risk

• 

  OncoLog, Volume 57, Number 10, October 2012

  Jill Delsigne and Sunni Hosemann

  • Treatments May Alleviate and Reverse Central Nervous System Radiation Necrosis: Although radiation therapy is effective against many tumors of the brain and spine, it also damages normal tissue
  • INBRIEF: Bevacizumab With High-Dose Chemotherapy Shows Promise for Cisplatin-Refractory Germ Cell Tumors
  • Compass: Early-Stage Testicular Cancer-Postsurgical treatment varies according to tumor stage and histology
  • HOUSE CALL: Online Cancer Support Networks-Patients and caregivers find support online

• 

  OncoLog, Volume 57, Number 09, September 2012

  Zach Bohannan and Sunita Patterson

  • Stereotactic Body Radiation Therapy Achieves High Control Rates in Lung Cancer: Stereotactic body radiation (SBRT), a relatively new treatment modality, has recently become a very successful treatment-and may even exceeded the effectiveness of surgery-for early-stage lung cancer
  • Inflammatory Breast Cancer: Clinical Challenge, Research Enigma- Inflammatory breast cancer (IBC) stands apart from other cancers of the breast in its unusual clinical presentation, its aggressiveness, and its poor prognosis. Researchers and clinicians are working to clarify what distinguishes IBC from other breast cancers and to discover treatments that improve patient outcomes
  • HOUSE CALL: Reducing Cancer-Causing Chemicals in Outdoor Cooking: Tips for healthy grilling

• 

  OncoLog, Volume 57, Number 08, August 2012

  Amelia Scholtz and Dawn Chalaire

  • Preoperative Chemotherapy Offers Best Outcomes for Patients with Rare Bladder Cancer: A combination of neoadjuvant chemotherapy and surgery provides patients who have small-cell urothelial cancer (SCUC) with much longer survival times than does initial surgery, the previous standard treatment
  • Addressing Psychological Concerns for Cancer Patients: Despite advances in cancer treatment over the past several years, for many people, a diagnosis of cancer can still feel like a death sentence. The added stress leads to psychological problems for many patterns
  • INBRIEF: New Antibody Treatment Produces Responses in Patient with Advanced Cancer/Accelerated Partial-Breast Brachytherapy Associated with Decreased Long-Term Breast Preservation and Increased Complications Compared with Whole-Breast Irradiation/ Circulating Tumor Cells Have Predictive Value in Early-Stage Breast Cancer
  • HOUSE CALL: Cancer Treatment Myths: Misconceptions can be dangerous

• 

  OncoLog, Volume 57, Number 07, July 2012

  Kathryn L. Hale and Sunni Hosemann

  • Geriatricians Play an Increasingly Important Role in Cancer care: In the past, many elderly patients did not survive long after a cancer diagnosis. Even older patients who were healthy enough to undergo the standard treatment for their cancer often had a shorter life expectancy than younger people with the same cancer
  • Compass: Early -Stage Cervical Cancer: Treatment choices vary according to disease stage and patient-specific factors
  • HOUSE CALL: Exercise and Cancer Prevention: Benefits of exercise apply to a variety of cancers

• 

  OncoLog, Volume 57, Number 06, June 2012

  Sarah Bronson and Stephanie Deming

  • Minimally Invasive Component Separation Reduces Wound-Healing Complications from Abdominal Surgery: Component separation, a major advance in abdominal wall reconstruction, can prevent hernia recurrence in many patients
  • Bevacizumab for Glioblastoma: Symptom Relief Proven, Overall Survival Benefit Being Studied-The antiangiogenic agent bevacizumab has been shown to prolong progression-free survival and ameliorate symptoms in patients with recurrent glioblastoma. However, it remains unknown whether bevacizumab should be used to treat newly diagnosed glioblastoma and whether bevacizumab prolongs the overall survival of patients with glioblastoma
  • HOUSE CALL: Hospice Care- Patients and families have choices for care and comfort
  • INBRIEF: Panobinostat Elicits Durable Response in Hodgkin Lymphoma

• 

  OncoLog, Volume 57, Number 05, May 2012

  Bryan Tutt and Sunni Hosemann

  • Advances in Gene Mapping Technology May Accelerate Cancer Drug Development: As new technology makes DNA sequencing faster and less expensive, researchers aim to exploit these abilities to develop novel targeted cancer therapies
  • Compass: Advanced Renal Cell Carcinoma: Surgery and/or systemic therapy can help manage disease
  • HOUSE CALL: Do Nutritional Supplements Help Prevent Cancer ?: For many people, the risks may outweigh the benefits
  • INBRIEF: Drug Provides Symptom Reduction and Survival Advantages for Myelofibrosis Patients

• 

  OncoLog, Volume 57, Number 04, April 2012

  Joe Munch and Bryan Tutt

  • Biology, More Than Chemotherapy Timing, Drives Locoregional Recurrence in Patients Who Undergo Breast-Conserving Therapy: The management of breast cancer, like that of many cancers, often requires a little bit of everything: surgery, radiation therapy, and systemic therapy with chemotherapeutic drugs or other agents
  • New Treatments for Acute Myelogenous Leukemia May Improve Patient Outcomes: Acute myelogenous leukemia (AML) is an aggressive and deadly malignancy, nut new treatments are being developed that may prolong remissions
  • HOUSE CALL: Controlling Nausea and Vomiting from Chemotherapy: Several techniques can be used to prevent or reduce this side effect

• 

  OncoLog, Volume 57, Number 03, March 2012

  Zach Bohannan, Sarah Bronson, and Bryan Tutt

  • Precision Robotic Tools Facilitate Minimally Invasive Prostectomy: Surgeons face a treacherous landscape when they perform a proctectomy
  • Fluorescence Cystoscopy Detects Hard-to-Find Bladder Tumors: Fluorescence cystoscopy, although not yet widely used in United States, has been shown to be effective for detecting tumors in the bladder that might not be visible with standard cystoscopy
  • New HPV Vaccine Recommendations Could Have Multiple Benefits: New recommendations for vaccination against human papillomavirus (HPV) are intended to prevent cervical cancer but may also decrease the incidence rates of other cancers
  • HOUSE CALL: Tanning Beds Pose Health Risks: Dangers of tanning range from wrinkled skin to cancer
  • INBRIEF: T Cell Therapy Prolongs Survival in Dogs With Non-Hodgkin Lymphoma

• 

  OncoLog, Volume 57, Number 02, February 2012

  Don Norwood and Bryan Tutt

  • Pediatric and Adult Cancer Patients Face Different Issues in Care, Survivorship: The challenges faced by children and adults with cancer can differ markedly, even when they have the same type of cancer
  • Palliative Care May Offer Survival Benefits: Recent studies indicate that palliative care, which has been shown to improve quality of life in patients with advanced cancer, may also help patients live longer
  • INBRIEF: Targeted Therapy Causes Chronic Lymphocytic Leukemia Remission/Study Finds Acupuncture Can Prevent Radiation-Induced Chronic Dry Mouth
  • HOUSE CALL: Understanding the risks, benefits, and purpose of a trial can help cancer patients decide whether to participate

• 

  OncoLog, Volume 57, Number 01, January 2012

  Joe Munch and Sunni Hosemann

  • Meeting Needs of Cancer Survivors: Thanks to new treatments and early detection, many types of cancer can be cured or managed, and more cancer patients are surviving than in the past. These long-term survivors have unique health care needs that are just beginning to be understood.
  • Compass: Locally Advanced Squamous Cell carcinoma of the Tonsil- Advances in surgical techniques may broaden treatment options for some patients.
  • HOUSE CALL: Sex after Cancer Treatment- Many cancer-related sexual problems can be solved

• 

  Oncology, Volume 56, Number 11-12, November - December 2011

  Sarah Bronson and Zach-Bryan Bogannan-Tutt

  • Transoral Laser Microsurgery for Laryngeal and Oropharyngeal Tumors: A minimally invasive surgery for treating cancers of the larynx and oropharynx has cute rates similar to those of open surgery and radiation therapy in selected patients.
  • Exploring Causes of and Treatments for Neuropathy in Cancer Patients: Among the most troubling side effects of cancer treatment in some patient is chronic chemotherapy neuropathy syndrome, in which tingling, numbness, and pain in the hands and feet persist long after the completion of treatment
  • Prostate Cancer Screening: Patient should understand the purpose and limitations of the prostate-specific antigen test
  • HOUSE CALL: Smoking Cessation: Medications Help smokers quit
  • IN BRIEF: BRCA2 Mutations in Ovarian Cancers Indicate High Rates of Survival and Treatment Response for Patients

• 

  Oncology, Volume 56, Number 10, October 2011

  Bryan Tutt and Sunni Hosemann

  • Treating Cancer in Pregnant Patients: Pregnancy is usually a joyous, hopeful time; a cancer diagnosis can be devastating. When pregnancy and cancer occur together, they present special challenges for patients and physicians. Fortunately, these challenges often can be overcome by a multidisciplinary approach to treatment
  • Compass: Non-Small Cell Lung Cancer: Stage IIIA-Many factors affect treatment sequences
  • HOUSE CALL: Understanding Cancer Risk and Risk Factors: Your risk factors might affect your need for cancer screening

• 

  Oncology, Volume 56, Number 09, September 2011

  Joe Munch and Bryan Tutt

  • Novel Agents for Castrate-Resistant Prostate Cancer Include Potent Androgen Blockers and Immunotherapies: Despite progress in screening and therapy, prostate cancer continues to be a leading cause of cancer death among men worldwide
  • New Targeted Therapy Offers Hope in Relapsed Hodgkin and Anaplastic large-Cell Lymphoma: The U.S. Food and Drug Administration (FDA) has approved the first new drug for Hodgkin Lymphoma since 1977
  • HOUSE CALL: Colorectal Cancer Screening: Risk factors determine who should be screened and how often
  • IN BRIEF: Everolimus may Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer Patients

• 

  Oncology, Volume 56, Number 08, August 2011

  Stephanie Deming and Sunni Hosemann

  • Addressing the Cardiac Complications of Cancer Treatment: Patients with cancer surviving longer than ever after treatment, and new targeted therapy agents are being introduced into the clinic with increasing frequency. These advances are cause for optimism, but they have also led to an increased incidence of cardiac complications of cancer therapy
  • Compass: Early- and Intermediate-Stage Gastric Cancer: Neoadjuvant of adjuvant treatments offer higher cure rates than surgery alone
  • HOUSE CALL: Managing Disease-Related Fatigue- Patients and doctors offer can make fatigue less severe

• 

  OncoLog, Volume 56, Number 07, July 2011

  Kate Newberry and Joe Munch

  • A New Era in Treating Patients Who Have Multiple Myeloma: During the past decade, several novel treatments have extended the median survival time for patients with multiple myeloma from less than 3 years to more than 7 years, and researchers are working to further improve treatment
  • Landmark Trial Shows Potential of Low-Dose Computed Tomography for Lung Cancer Screening
  • HOUSE CALL: Eating Healthier May Reduce Cancer Risk: Healthy eating habits may also increase energy and heart health
  • IN BRIEF: Inotuzumab Ozogamicin Shows Promise for Acute Lymphoblastic Leukemia Treatment

• 

  OncoLog, Volume 56, Number 06, June 2011

  John H. McCool and Sunni Hoseman

  • MD Anderson Celebrates 70th Anniversary: Its first clinical facility was a converted Army barracks, its first headquarters was renovated residential estate near downtown Houston, and its first cancer research was conducted by four scientists in a former horse stable
  • Compass: Stage II or III Soft Tissue Sarcoma-Chemotherapy and radiation therapy before or after surgery benefit patients

• 

  OncoLog, Volume 56, Number 04-05, April-May 2011

  Zach Bohannan and Bryan Tutt

  • Understanding and Managing Multiple Endocrine Neoplasia Syndromes: Endocrine tumors caused by multiple endocrine neoplasia syndromes (MEN) pose a dual threat-both from the tumors' potential for growth or metastasis and from their hormonal secretions
  • Two-Stage Resection and Improved Chemotherapy Regimens Lengthen Survival for Patients with Lever Metastasis from Colorectal Cancer
  • HOUSE CALL: Saving a Life by Donating Stem Cells: Fact about stem cell transplants
  • IN BRIEF: Study Reveals How EZH2 Protein Promotes Breast Tumor-Initiating Cell Growth

• 

  OncoLog, Volume 56, Number 03, March 2011

  Bryan Tutt and Joe Munch

  • Glioblastoma Cure Remains Elusive Despite Treatment Advances: Aggressive surgery followed by radiation therapy and chemo-therapy offers hope of long-term survival for some patients with glioblastoma, but for most glioblastoma patients, the prognosis is poor
  • Assessing and Addressing the Biological Effects of Stress in Cancer Patients: Stress has long been linked to cancer progression. But the precise mechanisms by which stress exacts its pro-tumor effects are not fully understood
  • MD Anderson One of Four Centers to Test Cancer Cell Detection Chip: A new test that could monitor the effectiveness of cancer treatment
  • HOUSE CALL: Yoga and Tai Chi: Two distinct disciplines offer similar physical and psychological benefits: In the shadow of their New Year's resolutions, many people seek out the gym to improve their physical and mental well-being/ Differences and similarities/ Benefits of mind-body exercise

• 

  OncoLog, Volume 56, Number 02, February 2011

  Joe Munch and John LeBas

  • Risk-Based Cancer Screening: M.D. Anderson's revised guidelines offer more precise individualized recommendations on screening for common cancers.
  • Screen Guidelines in Brief
  • Electronic Navigation Biopsy for Peripheral Lung Lesion Diagnosis
  • House Call: Couples and Cancer: Cancer-Related Issues Can Disrupt Relationships
  • in Brief: Researchers Find Glioblastoma's Resistance to Treatment Rooted in Immunosuppression

• 

  OncoLog, Volume 56, Number 01, January 2011

  Bryan Tutt and Sunni Hosemann

  • New Drug Control Symptoms of Myeloproliferative Disorders and Improve Quality of Life for Patients: Recent clinical trials have demonstrated that a new class of drugs can effectively treat myeloproliferative disorders
  • Compass: Metastatic Melanoma: Experimental treatments could be preferable to standard therapies for metastatic melanoma
  • HOUS CALL: Breast Awareness: Guidelines recommend breast awareness rather than formal self-exams

• 

  OncoLog Volume 55, Number 11-12, November-December 2010

  Bryan Tutt and Joe Munch

  • Desmoid Tumors: Multidiciplinary treatment for an enigmatic disease
  • Endoscopic Surgery for Skull Base Tumors: Patient selection is the key to success for the minimally invasive procedure
  • INBRIEF: Earlier Breast Cancer Screening Recommended for Hispanic Women/SUMO Is Important for DNA Damage Repair/Regional Care Centers Make Cancer Treatment Easily Accessible/SIK2 Plays Critical Role in Chemotherapy Resistance
  • HOUSE CALL: Books Provide Comfort, Guidence, Relaxation

• 

  OncoLog Volume 55, Number 10, October 2010

  Sunni Hoseman and Stephanie Deming

  • Protecting the Patient during Radiation Theraphy: Staff expertise and equipment accuracy are essential to safe and effective treatment
  • Compass Fall 2010: Stage II Colon Cancer: Adjuvant Therapy? After Surgery, some patients benefit from chemotherapy
  • HOUSE CALL: Managing Cancer-Related Pain
  • INBRIEF: Researchers identify Enzyme Involved in Chemotherapy Resistance

• 

  OncoLog Volume 55, Number 09, September 2010

  Sunita Patterson and John LeBas

  • Tiny Particales, vast Potential-Coming soon to the clinic: nanoparticles that deliver therapy straight to tumor cells, bypassing normal cells and many toxic effects
  • Non-Hodgkin Lymphomas: Targeted Therapies Leading Treatment Advances
  • HOUSE CALL: Writing for Wellness: Keeping a Journal
  • INBRIEF: Study Shows Abnormal Cells in Blood Increase with Lung Cancer Stage

• 

  OncoLog Volume 55, Number 08, August 2010

  Bryan Tutt and John LeBas

  • Therapeutic Vaccines against Cancer: Clinical trials of thrapeutic vaccines in cancer patients yield positive results
  • Findings Could Altere Chronic Myelogenous Leukemia Treatment: Phase III trials show newer drugs yield better responses than imatinib
  • INBRIEF: Vandetanib Shows Benefit When Combined with Docetaxel for Lung Cancer/ HPV-Positive Tumor Status Indicates Better Prognosis in Patients with Oropharyngeal Cancer
  • HOUSE CALL: Understanding the Benefits and Risks of Massage

• 

  OncoLog Volume 55, Number 07, July 2010

  Joe Munch and Sunni Hoseman

  • Refining Approaches to Thyroid Cancer: Time-proven treatments and newer biologic agents offer hope, particularly for patirnts with advanced disease.
  • Thyroid Cancer in Children.
  • Compass Summer 2010: Locoregional Cancer of the Esophagus: Timimg Surgery and Other Therapies for Resectable Disease.
  • HOUSE CALL: Understanding Clinical Trials

• 

  OncoLog Volume 55, Number 06, June 2010

  John LeBas

  • The BATTLE Results Are IN: Phase II trial reveals molecular signatures in lung cancer that may guide treatment decisions.
  • Endoscopic Repair of Colon Perforations: Nonsurgical techniques for closing gestrointestinal defects may yiels benefits for patients undergoing colonoscopy.
  • INBRIEF: Stem Cells Seen Repairing Heart Attack Damage Over Time/Additional Blood Data May Improve Pediatric Leukemia Predictions/Pediatric Patients with Rare Tumor May benefit from Heated Chemotherapy/New Findings Refute Link Between UVA, Melanoma.
  • HOUSE CALL: Skin Cancer Screening: What is It and Who Should Get It ?: Types of skin cancer/Who should be screened ?/What to expect/Self-examination: Check your skin regularly and tell your doctor about any suspicious changes

• 

  OncoLog Volume 55, Number 04-05, April-May 2010

  John LeBas and Sunni Hoseman

  • IMAGING NERVES: Tetnus Toxin Offers Promise for Neurography
  • INBRIEF: Fight-or-Flight Hormones Linked to Metastasis/Drug Combination Shows Promise for Colon Cancer Chemoprevention
  • Compass Spring 2010: Early Uterine Papillary Serous Carcinoma: Treatment Options Tailored to Patient and Disease Characteristcs
  • House Call: Addressing the Cosmetic Effects of Breast Cancer

• 

  OncoLog Volume 55, Number 03, March 2010

  Bryan Tutt and Joe Munch

  • Benign Tumors That Cause Big Problems:Fortunately, parathyroid tumors can be removed with minimally invasive surgery.
  • Preventing Bone Loss nad Fractures in Cancer Patients
  • INBRIEF: Leukemia Cells Observed Burning Fat to Evade Death/Assesment Tool Takes Aim at Graft-versus-Host Disease
  • House call: Immunotherapy:Boosting the Body's Fight Against Cancer

• 

  OncoLog Volume 55, Number 02, February 2010

  Joe Munch and John LeBas

  • Risk-Based Cancer Screening: M.D. Anderson's revised guidelines offer more precise individualized recommendations on screening for common cancers.
  • Screen Guidelines INBRIEF
  • Electronic Navigatin Biopsy for Peripheral Lung Lesion Diagnosis
  • House Call: Couples and Cancer: Cancer-Related Issues Can Disrupt Relationships
  • INBRIEF: Researchers Find Glioblastoma's Resistance to Treatment Rooted in Immunosuppression

• 

  OncoLog Volume 55, Number 01, January 2010

  Bryan Tutt and Bita Esmaeli

  "

  • Ocular Cancer: Tumors of the eye threaten sight and often indicate presence of extensive disease
  • Eye Care for Cancer Patients
  • Doctors Team Up to Battle Retinoblastoma
  • Compass Winter 2010: Ductal Carcinoma In Situ: Choosing Treatment for a Common Group of Early, Confined Breast Cancers
  • Toward Tomorrow
  • House Call: Three Targets for New Year's Resolutions

  "

• 

  OncoLog Volume 54, Number 11/12, November/December 2009

  Dawn Chalaire and Joe Munch

  • Treating Neurofibromatosis
  • Personalized Therapy for Lung Cancer
  • House Call: Genetic Screening for Cancer Risks Gives Patients Options

• 

  OncoLog Volume 54, Number 10, October 2009

  John LeBas and Bryan Tutt

  • Early Testicular Cancer
  • Metastatic Rectal Cancer
  • House Call: What Is Pancreatic Cancer?

• 

  OncoLog Volume 54, Number 09, September 2009

  John LeBas and Joe Munch

  • Addressing the Lifetime Needs of Survivors
  • Renal Tumors
  • House Call: Preparing for a Hospital Stay

• 

  OncoLog Volume 54, Number 07/08, July/August 2009

  John LeBas, Sunni Hosemann, and Bryan Tutt

  • Frontiers in Radiosurgery
  • Advanced Ovarian Cancer
  • House Call: Colorectal Cancer: Life-Saving Options for Early Detection
  • Reduced Wait Times Mean Faster Access for New Patients

• 

  OncoLog Volume 54, Number 06, June 2009

  John LeBas and Maude Veech

  • Chronic Myelogenous Leukemia: Refining Approaches to Treatment
  • Advancing the Treatment of Lymphedema
  • House Call: Hospice: Comforting Care When the End Is Near

• 

  OncoLog Volume 54, Number 05, May 2009

  John LeBas

  • Targeting Inflammation in Cancer Prevention
  • Treating Radiation Necrosis of the Brain
  • Preclinical Studies Reveal Effectiveness of Therapies for Pediatric Cancers
  • House Call: Protect and Check Your Skin

• 

  OncoLog Volume 54, Number 04, April 2009

  Sunita Patterson and Sunni Hosemann

  • Rebuilding What Cancer Has Ravaged
  • Organ-Confined Prostate Cancer
  • House Call: Integrative Medicine: Understanding Complementary and Alternative Therapies

• 

  OncoLog Volume 54, Number 03, March 2009

  Joe Munch

  • Rare Tumors: Finding Common Ground
  • Neuroendocrine Tumors
  • House Call: How You Can Help a Seriously Ill Friend

• 

  OncoLog Volume 54, Number 02, February 2009

  Maude Veech, Joe Munch, and Don Norwood

  • Accelerated Partial Breast Irradiation: A Promising Adjuvant to Lumpectomy Acute Lymphoblastic Leukemia: Pediatric Regimens for Adolescents and
  • House Call: Think About Your Medical Needs When Preparing for Natural Disasters
  • Young Adults Yield Survival Advantages
  • A New Biomarker for Bladder Cancer?

• 

  OncoLog Volume 54, Number 01, January 2009

  John LeBas and Sunni Hosemann

  • Redefining Cancer Care
  • Early-Stage Laryngeal Cancer
  • House Call: Trouble Sleeping? Getting Help Can Improve Your Health

• 

  OncoLog Volume 53 Number 12, December 2008

  Stephanie P. Deming and Virginia M. Mohlere

  • Mantle Cell Lymphoma
  • Sparing the Nipple During Mastectomy
  • House Call: Taking Medicine? Be Aware of Food-Drug Interactions

• 

  OncoLog Volume 51, Number 02, February 2006

  Sunni Hosemann and Ellen McDonald PhD

  • Emergency Care for Cancer Patients
  • Bringing Clinical Trials to the Community
  • House Call: Understanding the Immune System
  • DiaLog: Cognitive Dysfunction in Cancer, by Christina Meyers, PhD, Professor and Chief, Section of Neuropsychology

• 

  OncoLog Volume 51, Number 01, January 2006

  Stephanie P. Deming and Diane Witter

  • Fertility After Cancer
  • Improving the Odds in Lung Cancer
  • House Call: Understanding the Basics of Melanoma

• 

  OncoLog Volume 53, Number 01, January 2008

  John LeBas and Don Norwood

  • Prostate Cancer: A Tale of Two Therapies
  • In Brief: Newly Identified Gene May Stop Development of Lung Cancers
  • House Call: What You Should Know About Male Cancers
  • Making Headway Against Myeloproliferative Disorders

• 

  OncoLog Volume 53, Number 02, February 2008

  Joe Munch, Diane Witter, and Guillermo Garcia-Manero MD

  • Assessing Symptom Burden in Cancer
  • DiaLog: Making Headway in Hematology, by Guillermo Garcia-Manero, MD, Associate Professor, Department of Leukemia
  • Helping Kids Make Smart Food Choices
  • Expanding Therapy Options for Advanced Cancer

• 

  OncoLog Volume 53, Number 03, March 2008

  John LeBas and Gordon B. Mills MD, PhD

  • In Search of the Answer
  • DiaLog: Mapping the Cancer Genome, by Gordon Mills, MD, PhD, Director, Kleberg Center for Molecular Markers, Chair, Department of Systems Biology
  • House Call: The Basics of Biopsies

• 

  OncoLog Volume 53, Number 04, April 2008

  Diane Witter, John LeBas, and Sunni Hosemann

  • Cancer as a Chronic Disease
  • In Brief: Cancer-Promoting Protein in Ovarian Cancer May Be Stopped with RNA Liposome
  • House Call: Caring for the Caregiver
  • Barely Benign

• 

  OncoLog Volume 53, Number 05, May 2008

  John LeBas; Joe Munch; and Alexander V. Prokhorov MD, PhD

  • Hepatocellular Carcinoma: New Standards in Therapy Emerging
  • House Call: When Diagnosis Meets Denial
  • In Brief: Overweight, Obese Patients Fare Worse with Breast Cancer, Researchers Find
  • DiaLog: ASPIRE to Stop Teen Smoking, by Alexander V. Prokhorov, MD, PhD, Project Director, ASPIRE, Professor, Department of Behavioral Science
  • A Reverse Approach to Adrenal Gland Resection

• 

  OncoLog Volume 53, Number 06, June 2008

  Karen Stuyck, Virginia M. Mohlere, David Stouter, and David Jenkins

  • Psychotherapy Extends Cancer Care Beyond the Physical
  • House Call: Understanding How Cancer Spreads
  • DiaLog: Teaming Spiritual and Medical Care, by Rev. David Stouter, Chaplain, Department of Chaplaincy and Pastoral Education, and Rev. David Jenkins, Director, Department of Chaplaincy and Pastoral Education
  • Radical Trachelectomy: A Fertility-Sparing Option for Invasive Cervical Cancer

• 

  OncoLog Volume 53, Number 07/08, July/August 2008

  John LeBas and Sunni Hosemann

  • Multiple Myeloma: Increasing Response, Remission, and Survival Rates in a Complex Disease
  • House Call: A Guide to Radiation Therapy
  • In Brief: Researchers Enhance Anticancer Activity of Natural Killer Cells in Laboratory
  • Beyond Images: Advances in Interventional Radiology
  • Radioembolotherapy Using Yttrium 90

• 

  OncoLog Volume 53, Number 09, September 2008

  Maude Veech and Dawn Chalaire

  • Deciphering Metastatic Colorectal Carcinoma
  • House Call: Planning Ahead with Advance Directives
  • A Child-Centered Approach to Anesthesia for Proton Therapy

• 

  OncoLog Volume 53, Number 10, October 2008

  Joe Munch and Sunita Patterson

  • Pancreatic Cancer: The Prognosis Is Changing
  • Delivering “The Guardian of the Genome”
  • House Call: “Seeing” Cancer from the Outside
  • Catching Pancreatic Cancer Early

• 

  OncoLog Volume 53, Number 11, November 2008

  John LeBas and Sunni Hosemann

  • Options for Malignant Pleural Mesothelioma
  • House Call: Saying No to Smoking: When You Need More than Willpower
  • Intermediate-Stage Bladder Cancer: Deciding on Preoperative Chemotherapy and Urinary Diversion

• 

  OncoLog, Volume 52, Number 11, November 2007

  Diane Witter, Karen Stuyck, and Garth Powis DPhil

  • Outsmarting Brain Cancer
  • Protecting the Heart
  • House Call: Recognize the Signs of Ovarian Cancer
  • DiaLog: Advancing Drug Design in Academia, by Garth Powis, DPhil, Director, Center for Targeted Therapy, Chair, Department of Experimental Therapeutics

• 

  OncoLog, Volume 52, Number 04/05, April/May 2007

  Manny Gonzales, Diane Witter, and Moshe Frenkel MD

  • Endocrine Center Unites Specialists
  • Prescribing Hormone Replacement: What Now?
  • House Call: Writing for Wellness: Keeping a Journal\
  • DiaLog: What Your Patients Aren’t Telling You, by Moshe Frenkel, MD, Associate Professor, Medical Director, Integrative Medicine Program

• 

  OncoLog, Volume 52, Number 03, March 2007

  Sunni Hosemann, Karen Stuyck, and Elizabeth L. Travis PhD

  • New Approaches for Advanced Melanoma
  • Helping Patients Stop Smoking
  • House Call: Simple Skin Cancer Prevention
  • DiaLog: Toward Gender Equity in Academic Medicine, by Elizabeth Travis, PhD, Associate Vice President, Women Faculty Programs

• 

  OncoLog, Volume 52, Number 02, February 2007

  Diane Witter

  • New Findings on Aspirin and Heart Attacks
  • Kicking Off a Trend: Cancer-Related Deaths Decline
  • House Call: Working Out How to Lower Your Risk of Cancer

• 

  OncoLog, Volume 52, Number 01, January 2007

  Dawn Chalaire; Don Norwood; and Robert Buckman MD, PhD

  • Toward Personalized Medicine
  • Making Strides in Esophageal Cancer
  • House Call: Eat Well, Live Longer
  • DiaLog: The Secret of Good "Person-Doctoring", by Robert Buckman, MD, PhD, Adjunct Professor of Neuro­-Oncology, M. D. Anderson Professor, University of Toronto

• 

  OncoLog, Volume 52, Number 06, June 2007

  Don Norwood and Diane Witter

  • Advances in Stem Cell Transplantation
  • More Is Better, But How Much Is Enough?
  • House Call: Save a Life by Donating Stem Cells
  • Project FAROS Enrolling Local Hispanics in Study of Health Care Access

• 

  OncoLog, Volume 52, Number 07/08, July/August 2007

  Diane Witter, Vickie J. Williams, and Dawn Chalaire

  • Harnessing the Power of Protons
  • Gene-Environment Interaction Studies Answer the Question, “Why Did I Get Cancer?”
  • House Call: Parents: Be Hopeful and Honest When Telling Kids about Your Serious Illness
  • Helping Physicians Help Patients

• 

  OncoLog, Volume 52, Number 09, September 2007

  Sunni Hosemann, Diane Witter, and Gabriel N. Hortobagyi MD

  • Sparing Life and Limb
  • Can a Common Spice Be Use to Treat Cancer?
  • House Call: Your First Colonoscopy: Here's What You Can Expect
  • DiaLog: Targeted Therapies Are Here to Stay, by Gabriel N. Hortobagyi, MD

• 

  OncoLog, Volume 52, Number 10, October 2007

  Diane Witter; Vickie J. Williams; and Michael Fisch MD, MPH

  • Cancer Chemoprevention: A Prescription for Health?
  • Clinic Targets Oral Cancer at Early Stages
  • Customized Cancer Care for Kids
  • Hotline Consultation Available for Suspected Cancer Cases
  • House Call: Cancer Stages: Understanding the Basics
  • DiaLog: Rethinking the Standard of Care, by Michael Fisch, MD, MPH

• 

  OncoLog, Volume 52, Number 12, December 2007

  Sunni Hosemann, Diane Witter, and Huong Le-Petross MD

  • Worth More than a Thousand Words\
  • A Step Forward for Stents
  • House Call: Getting the Most From Your Doctor Visit
  • DiaLog: Is MRI Better for Breast Screening?, by Huong Le-Petross, MD

• 

  OncoLog Volume 51, Number 12, December 2006

  Sunni Hosemann

  • Curable But Not Conquered: Hodgkin’s Lymphoma Today
  • House Call: Big Benefits for Smokers Who Quit

• 

  OncoLog Volume 51, Number 11, November 2006

  Sunni Hosemann and Reginald F. Munden MD

  • Treating Skull Base Tumors
  • Targeting Inflammatory Breast Cancer
  • House Call: On the Job with Cancer
  • DiaLog: Helical CT Screening: Does It Affect Lung Cancer Outcome? by Reginald F. Munden, MD, Professor, Department of Diagnostic Radiology

• 

  OncoLog Volume 51, Number 10, October 2006

  Ellen McDonald PhD

  • Robotic Surgical System Lends a Hand (Actually, 4 Hands)
  • House Call: Q&A: Should You Take Part in a Clinical Trial?

• 

  OncoLog Volume 51, Number 09, September 2006

  Dawn Chalaire, Angelique Siy, and Christopher G. Wood MD

  • Zeroing In on a Moving Target
  • New Life for an Old Drug
  • House Call: Managing Your Medications
  • DiaLog: Adjuvant Therapy for Aggressive Kidney Cancer, by Christopher G. Wood, MD, Associate Professor of Urology and Cancer Biology

• 

  OncoLog Volume 51, Number 07/08, July/August 2006

  Diane Witter, Sunni Hosemann, and Elihu Estey MD

  • Gaining Momentum in MDS
  • When Bone Marrow Goes Awry
  • Pancreatic Cancer: It Takes a Village
  • House Call: Tired of Being Tired
  • DiaLog: Anemia in the Elderly, by Elihu Estey, MD, Professor, Department of Leukemia

• 

  OncoLog Volume 51, Number 06, June 2006

  Karen Stuyck and Manny Gonzales

  • Breast Cancer in the Prime of Life
  • Early Nutritional Intervention Recommended for Cancer Patients
  • House Call: How to Deal with Pain

• 

  OncoLog Volume 51, Number 05, May 2006

  Sunni Hosemann, Kathryn Carnes, and Patrick Hwu MD

  • A Better Kind of Brain Surgery
  • Raloxifene Effective for Breast Cancer Prevention
  • House Call: The Many Benefits of Massage
  • DiaLog: Cancer Vaccines and Immunotherapy, by Patrick Hwu, MD, Professor and Chair, Melanoma Medical Oncology

• 

  OncoLog Volume 51, Number 04, April 2006

  Sunni Hosemann, Martha Morrison, and Therese B. Bevers MD

  • Redefining Unresectable Disease: Strategies for Treating Liver Metastases from Colorectal Cancer
  • Cancer Screening Guidelines Revised: One on One with Dr. Therese Bevers
  • House Call; What Is "Breast Self-Awareness"?
  • DiaLog: The Revolutionary Cervical Cancer Vaccine, by Therese B. Bevers, MD, Medical Director, Cancer Prevention Center

• 

  OncoLog Volume 51, Number 03, March 2006

  Dawn Chalaire and Martha Morrison

  • What Happens Next? Managing the Care of Long-Term Cancer Survivors
  • House Call: Relieving Symptoms with Acupuncture
  • 50 Years of OncoLog

• 

  OncoLog, Volume 50, Number 12, December 2005

  Sunni Hosemann and Diane Witter

  • Moving New Drugs from "Bench to Bedside and Back"
  • House Call: When the End Is Near: Ways to Cope When a Loved One Is Terminally Ill
  • After Katrina: Caring for Cancer Patients in the Wake of the Storm

• 

  OncoLog, Volume 50, Number 11, November 2005

  Vickie J. Williams, Karen Stuyck, and James D. Cox MD

  • Cancer in Young Adults
  • Do Mind/Body Techniques Work?
  • House Call: Tapping into Local and Online Resources
  • Phytoestrogen Consumption May Reduce Lung Cancer Risk
  • DiaLog: Radiation Therapy and Lung Cancer, by James D. Cox, MD, Professor and Head of the Division of Radiation Oncology

• 

  OncoLog, Volume 50, Number 10, October 2005

  Beth Notzon, Rachel Williams, and Maurie Markman MD

  • Cytogenetics: Major Insights from Microscopic Details
  • Breaking the News
  • House Call: From My Bookshelf to Yours
  • DiaLog: Intraperitoneal Chemotherapy: A New Strategy for Advanced Ovarian Cancer, by Maurie Markman, MD, Vice President for Clinical Research

• 

  OncoLog, Volume 50, Number 09, September 2005

  Don Norwood, Razelle Kurzrock MD, and Robert S. Benjamin MD

  • A New Source of Stem Cells
  • House Call: Complementary and Alternative Medicine: Sorting through the Choices
  • DiaLog: Risks and Benefits of Phase I Oncology Trials, by Razelle Kurzrock, MD, Professor, Division of Cancer Medicine Phase I Program, and Robert S. Benjamin, MD, Professor, Department of Sarcoma Medical Oncology

• 

  OncoLog, Volume 50, Number 07/08, July-August 2005

  Rachel Williams and Sunni Hosemann

  • Getting Proactive About Prevention
  • New Techniques in Tumor Ablation
  • House Call: Calling for Help: Cancer Helplines and What They Offer

• 

  OncoLog, Volume 50, Number 06, June 2005

  Karen Stuyck, Ellen McDonald, and Therese Bevers MD

  • Teen-Savvy Smoking Prevention
  • Considering Prophylactic Surgery, Part II
  • House Call: From Patient to Patient: Real-World Coping Tips
  • DiaLog: Enrolling Patients in Prevention Trials, by Therese B. Bevers, MD, Associate Professor, Department of Clinical Cancer Prevention

• 

  OncoLog, Volume 50, Number 05, May 2005

  Dawn Chalaire and Jonathan M. Kurie MD

  • Filling the Void
  • House Call: Understanding Your Blood Counts
  • DiaLog: Celebrex Trials Resume, by Jonathan M. Kurie, MD, Professor, Department of Thoracic/Head & Neck Medical Oncology

• 

  OncoLog, Volume 50, Number 04, April 2005

  Rachel Williams; Ellen McDonald; and Michael Fisch MD, MPH

  • Harnessing the Immune System: The Promise and Potential of Cancer Vaccines
  • Considering Prophylactic Surgery
  • House Call: Chemotherapy and Hair Loss
  • DiaLog: Redefining Success in Cancer Care, by Michael Fisch, MD, MPH, Medical Director, Community Clinical Oncology Program

• 

  OncoLog, Volume 50, Number 02/03, February/March 2005

  David Galloway

  • Biostatistically Speaking
  • Novel Drugs Address Gleevec Resistance
  • Obesity: A Weighty Contributor to Cancer
  • House Call: When a Friend Has Cancer

• 

  OncoLog, Volume 50, Number 01, January 2005

  Rachel Williams, Dawn Chalaire, Caren E. Blinka, Angelina Esparza, and Allen W. Burton MD

  • New Perspectives on Brain Metastasis
  • Out of the Darkroom
  • Equity and Health
  • House Call: Blood and Platelet Donors Give Life
  • DiaLog: Cancer Pain Control in the New Millennium, by Allen W. Burton, MD, Section Chief, Cancer Pain Management Department of Anesthesiology and Pain Medicine

• 

  OncoLog, Volume 49, Number 12, December 2004

  David Galloway, Katie Prout Matias, Diane Witter, and Paul Mathew MD

  • Advances in Prostate Cancer Treatment
  • Everyday Drugs Show New Promise for Cancer
  • Are COX-2 Inhibitors Safe?
  • House Call: Myths & Facts about Cancer Prevention
  • DiaLog: Neoadjuvant Trials in Prostate Cancer, by Paul Mathew, MD, Assistant Professor, Department of Genitourinary Medical Oncology

• 

  OncoLog, Volume 49, Number 11, November 2004

  Rachel Williams and Steve C. Stuyck MPH

  • The Youngest Cancer Patients
  • Meeting the Rising Demand for Outpatient Care
  • House Call: Going Beyond the Headlines: Tips to help you evaluate cancer stories in the news media
  • DiaLog: Cancer Information in the Media, by Stephen C. Stuyck, MPH, Vice President for Public Affairs

• 

  OncoLog, Volume 49, Number 10, October 2004

  Dawn Chalaire; Sunni Hosemann; David Galloway; and Karen Basen-Engquist PhD, MPH

  • Treating Head and Neck Cancer Requires Extraordinary Coordination Among Disciplines
  • Researchers Seek to Understand the Mysteries of Uterine Cancer and to Find Better Treatments
  • Mammography vs. Magnetic Resonance Imaging: A Breast Cancer Prevention Specialist and a Radiologist Weigh in on the Recent Debate
  • House Call: The Role of Alcohol and Tobacco in Head and Neck Cancer
  • DiaLog: Sexuality after Gynecologic Cancer, by Karen Basen-Engquist, PhD, Associate Professor, Department of Behavioral Health

• 

  OncoLog, Volume 49, Number 09, September 2004

  Ellen McDonald, Ann Sutton, David Galloway, and Rena Sellin MD

  • New Approaches to Managing Tumors of the Pituitary Gland Offer Patients Hope
  • Needleless Chemotherapy: Safety and Efficacy of Aerosolized Chemotherapy Being Studied in Young Patients with Cancer
  • M. D. Anderson Physician Honored for Inventing an Antimicrobial Catheter That Prevents 25,000 Infection-Related Deaths a Year
  • House Call: How Cancer Happens and Ways to Lower Your Risk
  • DiaLog: Cancer-Related Neuroendocrine Dysfunction, by Rena V. Sellin, MD, Professor, Department of Endocrine Neoplasia and Hormonal Disorders

• 

  OncoLog, Volume 49, Number 07/08, July/August 2004

  Dawn Chalaire, David Galloway, and Ellen Manzullo MD

  • Proton Therapy Comes into Its Own
  • Treating Patients with Cancer Requires Looking Beyond the Tumor
  • House Call: Protecting Yourself Against Skin Cancer
  • DiaLog: Treating Cancer-Related Fatigue, by Ellen Manzullo, MD, FACP, Department of General Internal Medicine, Ambulatory Treatment, and Emergency Care

• 

  OncoLog, Volume 49, Number 06, June 2004

  Kate O'Suilleabhain, Katie Prout Matias, and Jack Roth MD

  • Despite Initial Setbacks, Researchers Are Focusing on Antiangiogenic Therapy More Than Ever
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging Predicts Response to Antiangiogenesis Agents
  • "Smart Bombs": Targeted Therapies Home in on Increasingly Well-Defined Targets
  • House Call: Understanding Angiogenesis
  • DiaLog: Gene Therapy for Cancer: Safety First, by Jack Roth, MD, Chair, Department of Thoracic and Cardiovascular Surgery

• 

  OncoLog, Volume 49, Number 05, May 2004

  David Galloway, Dawn Chalaire, and Emil J. Freireich MD

  • Experts Recommend Treating Cancer Pain in the Context of Other Symptoms
  • Protocols: Studies Examine Treatment for Cancer-Related Pain
  • Participation of Elderly Patients in Clinical Trials: Looking Beyond Age
  • House Call: From Cancer Research to Clinical Practice
  • DiaLog: The Next 20 Years: The Changing Face of Cancer Treatment, by Emil J. Freireich, MD, Director, Adult Leukemia Research Program

• 

  OncoLog, Volume 49, Number 04, April 2004

  Katie Prout Matias and Karen Stuyck

  • Gastric Cancer Studies Focus on Prolonging Survival and Finding Molecular Markers for Targeted Therapies
  • Clinical Ethicists Help Patients, Families, and Staff Resolve Difficult Dilemmas
  • An Unexpected Finding: Male Breast Cancer Is Rare and Often Overlooked
  • House Call: Getting Screened for Oral Cancer

• 

  OncoLog, Volume 49, Number 03, March 2004

  Beth Notzon and Katie Prout Matias

  • Translational Research Speeds the Journey from Lab Results to Clinical Outcomes
  • New Tests Could One Day Predict Response to Chemotherapy and Presence of Metastatic Disease in Patients with Breast Cancer
  • House Call: Mind-Body Approaches for Patients with Cancer

• 

  OncoLog, Volume 49, Number 02, February 2004

  Sunni Hosemann and Aurelio Matamoros

  • Colorectal Cancer Screening: Encouraging Compliance Today and Looking to the Future
  • Despite Its Drawbacks, Mammography Is Still Recommended
  • Communication Is Essential When Guiding Patients through the Maze of Genetic Breast Cancer Screening
  • House Call: Cancer Epidemiology, Step-by-Step
  • DiaLog: On Being a Volunteer, by Anderson Network volunteer

• 

  OncoLog, Volume 49, Number 01, January 2004

  David Galloway, Katie Prout Matias, Karin M.E.H. Gwyn MD, and Richard L. Theriault DO

  • Pregnancy and Cancer Treatment Often Are Not Mutually Exclusive
  • Studies of the Viral Origins of Some Cancers Lead to New Prevention, Treatment Strategies
  • House Call: Cancer and Your Weight
  • DiaLog: Treating Breast Cancer during Pregnancy, by Karin M.E.H. Gwyn, MD, Assistant Professor, and Richard L. Theriault, DO, Professor, Department of Breast Medical Oncology

• 

  OncoLog, Volume 48, Number 12, December 2003

  Karen Stuyck, Dawn Chalaire, Martha A. Askins PhD, and Martha Aschenbrenner

  • On the Move: Efforts Under Way to Improve Outcomes for Patients with Renal Cancer
  • Protocols: Studies Examine Treatments for Renal Cell Carcinoma
  • Art Therapy Helps Children Affected by Cancer Express Their Emotions
  • Children's Art Project Has Been Improving the Lives of Children with Cancer for 30 Years
  • DiaLog: When a Parent Is Sick: Talking to Children about Cancer, by Martha A. Askins, PhD, Division of Pediatrics, and Martha Aschenbrenner, Director, Child Life Services

• 

  OncoLog, Volume 48, Number 11, November 2003

  Sunni Hosemann and Don Norwood

  • Laparoscopy Shows a Benefit in a Growing Number of Oncologic Procedures
  • Collaboration and Creativity Lead to a New Approach to Spinal Surgery
  • Protocols: Studies Test New Surgical Procedures
  • House Call: Telling Fact from Fiction on the Internet

• 

  OncoLog, Volume 48, Number 10, October 2003

  Katie Prout Matias, Mariann Crapanzano, and Leslie R. Schrover PhD

  • 'Hitting Bladder Cancer on All Fronts': Researchers Focus on Improving Therapies and Identifying Biomarkers Restoring Erectile Function in Patients Treated for Prostate Cancer: Efforts across Disciplines Address Physical, Psychological, and Emotional Factors Related to Sexual Potency
  • House Call: Note to Self: Get Screened for Colon Cancer
  • DiaLog: Sexual Function and Prostate Cancer: The Importance of Realistic Expectations, by Leslie R. Schover, PhD, Professor, Department of Behavioral Science

• 

  OncoLog, Volume 48, Number 09, September 2003

  Katie Prout Matias, David Galloway, and Jeffrey E. Lee MD

  • Sentinel Lymph Node Biopsy: Detection of Micrometastases Leads to More Precise Staging of Breast and Melanoma Tumors
  • Sentinel Lymph Node Biopsy Shows Promise in Eye and Colon Cancers
  • New Research Promotes a More Dynamic View of Adult Stem Cell Differentiation: Hematopoietic Stem Cells May One Day Be Used to Repair Tissue Damage Caused by Radiation Therapy or Chemotherapy
  • House Call: Understanding the Buzz over Stem Cells
  • DiaLog: Directed Parathyroid Surgery, by Jeffrey E. Lee, MD, Professor, Department of Surgical Oncology

• 

  OncoLog, Volume 48, Number 07/08, July/August 2003

  Ann Sutton, Karen Stuyck, and Gayle Nesom

  • Researchers Explore Possible Applications of Nanotechnology in Cancer Treatment
  • Sharing the Burden: Palliative Care Team Helps Patients, Families Through Difficult Times
  • UPDATE: Study of Tamoxifen and Raloxifene (STAR) Nearing Completion Recruitment Efforts Focus on Women in Minority, Medically Underserved Populations
  • House Call: Getting the Best Treatment

• 

  OncoLog, Volume 48, Number 06, June 2003

  Dawn Chalaire, Sunni Hosemann, Kate O'Suilleabhain, Kerry L. Wright, and Daniel J. Booser MD

  • Largest-Ever NCI Trial to Study Lung Cancer Screening
  • “What Choices Do I Have?” Breast Reconstruction Book and CD-ROM Help Patients Make Complicated Decisions
  • House Call: Coping with the Adverse Effects of Cancer Treatment
  • New Proton Therapy Center to Deliver Radiation with Precision, Few Side Effects
  • DiaLog: Treating Breast Cancer with Hormone Therapy: Past, Present, and Future, by Daniel J. Booser, MD, FRCPC, Associate Professor, Department of Breast Medical Oncology

• 

  OncoLog, Volume 48, Number 05, May 2003

  Katie Prout Matias, David Galloway, and Ryuji Kobayashi PhD

  • Proteomics May One Day Revolutionize Cancer Detection, Staging, and Prognosis
  • Depression in Patients with Cancer Is a Separate—and Treatable—Illness
  • House Call: Facing Fatigue When You Have Cancer: What Can You Do?
  • DiaLog: Proteomics: The Creation of a New Field of Study, by Ryuji Kobayashi, PhD, Professor, Department of Molecular Pathology, Director, Proteomics Program

• 

  OncoLog, Volume 48, Number 04, April 2003

  Katie Prout Matias and Karen Stuyck

  • Study of Epigenetic Changes Leads to Treatment Advances in Adult Leukemias
  • Protocols: Studies Examine Treatment of Leukemia
  • The Cost of Caring: Dealing with the Stress of Being an Oncologist
  • Excerpts from Focus Groups Featured in Video to Help Oncologists Cope with Stress
  • House Call: Chemoprevention: Preventing Cancer with a Pill

• 

  OncoLog, Volume 48, Number 03, March 2003

  David Galloway, Ann Sutton, Katie Prout Matias, and Donna R. Copeland PhD

  • Pediatric Oncologists Search for More Effective Drugs to Treat an ‘Orphan Disease’
  • Collaborative Studies Lead to Better Survival Rates in Young Patients with Rhabdomyosarcoma
  • Protecting the Heart and Gastrointestinal Tract from Treatment-Associated Damage Is an Important Element of Cancer Care
  • House Call: Conquering the Pain of Cancer
  • DiaLog: Recognizing and Treating Cognitive Dysfunctions in Survivors of Childhood Cancers, by Donna R. Copeland, PhD, Professor, Department of Pediatrics

• 

  OncoLog, Volume 48, Number 02, February 2003

  Sunni Hosemann; Dawn Chalaire; and Michael J. Miller MD, FACS

  • Tissue Engineering: Several Avenues of Research Lead Toward a Single Goal
  • Researchers Design a Unique Stereotactic Radiotherapy and Radiosurgery System to Treat Patients with Paraspinal Metastases
  • House Call: Women and Lung Cancer: News You Can Use
  • DiaLog: Applying Tissue Engineering Techniques in the Clinic and the Laboratory, by Michael J. Miller, MD, FACS, Professor, Department of Plastic Surgery

• 

  OncoLog, Volume 48, Number 01, January 2003

  David Galloway, Stephanie Deming, and Heather Russell

  • Putting an End to the Waiting: Diagnosis Clinic Finds Answers for Patients When Cancer Is Suspected
  • The Center for Research on Minority Health: Working with the Community to End Health Disparities
  • Collaboration Between M. D. Anderson, University of Puerto Rico to Address Cancer in Minority Populations
  • House Call: Diagnostic Imaging Tests: How They Work and What to Expect

• 

  OncoLog, Volume 47, Number 12, December 2002

  Dawn Chalaire, Karen Stuyck, and Raymond Sawaya MD

  • Advances in Imaging Lead to More Targeted Radiation Treatments
  • Imaging Techniques Follow the Movements of Tumors During and Between Radiation Treatments
  • Evolution of Conformal Radiation Therapy Continues: IMRT Called 'the Next Level of Conformality'
  • DiaLog: The Caregiver: An Unsung Hero, by Raymond Sawaya, MD, Professor and Chair, Department of Neurosurgery
  • Support Groups, Classes Teach Caregivers How to Care for Patients and Themselves

• 

  OncoLog, Volume 47, Number 11, November 2002

  Mariann Crapanzano, Kerry L. Wright, and Frank A. Morello Jr. MD

  • Diagnosis Based on Nonsurgical Biopsy: A Cooperative Effort
  • Benign Care: Young Patients with a Variety of Noncancerous Conditions Find Treatment at M.D. Anderson Cancer Center
  • Cognitive Interventions Are Crucial for Many Patients with Neurofibromatosis
  • FNA Clinic Streamlines Biopsy Diagnosis of Palpable Lesions
  • "Is This Going to Hurt?", by Frank A. Morello Jr., MD, Assistant Professor, Section of Vascular and Interventional Radiology
  • House Call: Answers to Common Questions about the Use of Radioisotopes for Diagnosis

• 

  OncoLog, Volume 47, Number 10, October 2002

  Sunni Hosemann, Mariann Crapanzano, and Stephen P. Tomasovic PhD

  • A Natural Progression: M. D. Anderson Cancer Center Promotes the Study and Integration of Complementary Therapies
  • New AJCC Staging System for Hepatocellular Carcinoma Reflects Patient Prognosis After Surgical Resection
  • DiaLog: Complementary Medicine: Research, Education, and Communication, by Stephen P. Tomasovic, PhD, Professor of Molecular and Cellular Oncology and Vice President for Educational Programs
  • House Call: Making the Cancer Journey Easier

• 

  OncoLog, Volume 47, Number 09, September 2002

  Kerry L. Wright, Dawn Chalaire, Karyn Hede, Martin L. Smith STD, and Anne J. Flamm JD

  • Is Hormone Replacement Therapy an Option for Women with a History of Breast Cancer?
  • Breast Cancer Survivor Devotes Life to Helping Those at High Risk for Hereditary Cancers
  • "I Have Something to Tell You." Counselors Support Family Communication about Genetic Susceptibility to Cancer
  • DiaLog: Bigger than a Blood Test: Ethical Cautions about Genetic Testing, by Martin L. Smith, STD, and Anne J. Flamm, JD
  • House Call: Just a Phase: Understanding Clinical Trials
  • Discovery Sheds Light on How Breast Cancer Cells Progress to More Aggressive Forms

• 

  OncoLog, Volume 47, Number 07-08, July-August 2002

  Don Norwood, Sunni Hosemann, and Martin N. Raber MD

  • New Agents and Strategies Help Oncologists Balance Benefits and Risks of Chemotherapy
  • House Call: Exercise Improves Quality of Life for Patients with Cancer
  • Intravenous Administration of Busulfan Reveals a Therapeutic Window
  • Studies Look for Better Ways to Treat Infections in Patients with Cancer
  • DiaLog: Why Refer Patients to a Major Cancer Center?, by Martin N. Raber, MD, Professor of Medicine
  • Prevention, Early Diagnosis, and Effective Therapies Are Keys to Controlling Infections in Patients with Cancer

• 

  OncoLog, Volume 47, Number 06, June 2002

  Kate O'Suilleabhain, Dawn Chalaire, and Shellie M. Scott BS

  • Drug Development Program Paves the Way for FDA Approval of New Agents
  • Pediatric New Agents Working Group Advances the Study of Novel Treatments in Young Patients
  • DiaLog: Patients and Physicians: Partners in Health Care, by Shellie M. Scott, BS, Physician Assistant, Department of Urology
  • House Call: Taking a More Active Role in Your Own Health Care
  • As Population of Cancer Survivors Grows, Studies of Long-Term Health Effects Become More Critical, Researchers Say

• 

  OncoLog, Volume 47, Number 05, May 2002

  Kerry L. Wright, Ann Sutton, and Carmelita Escalante MD

  • Tobacco Research and Treatment Progra Studies Include Ways to Prevent and Treat Nicotine Dependence in Special Populations
  • Emergency Center Provides Specialized Care for M. D. Anderson Patients Experiencing Oncologic Emergencies
  • DiaLog: M. D. Anderson's Emergency Center, by Carmelita Escalante, MD, Associate Professor and Ad Interim Chair, Department of General Internal Medicine, Ambulatory Treatment, and Emergency Care
  • House Call: Depression and Cancer
  • Smoking Cessation Studies Blend Computer Technology with Behavioral Therapy

• 

  OncoLog, Volume 47, Number 04, April 2002

  Beth Notzon, Karen Stuyck, and Felipe Samaniego MD

  • Researchers Focus on Bioimmunotherap for Treatment of Non-Hodgkin's Lymphomas
  • Protocols: Non-Hodgkin's Lymphoma Studies
  • House Call: The First Cancer Prevention Vaccine
  • DiaLog: The Viral Origins of Lymphomas, by Felipe Samaniego, MD, Assistant Professor, Department of Lymphoma and Myeloma
  • Research Consortium Recruiting Volunteers to Study the Role of Genetics in Cancer Development and Patient Care

• 

  OncoLog, Volume 47, Number 03, March 2002

  Vickie J. Williams, Michael Worley, Noelle Heinze, and Richard J. Babaian MD

  • Largest-Ever Cancer Prevention Study to Examine the Effects of Selenium and Vitamin E on Prostate Cancer Occurrence
  • Protocols: Prostate Cancer Clinical Trials
  • House Call: Understanding Metastasis
  • DiaLog: The Prostate--Specific Antigen Test: Reliability and Recommended Use, by Richard J. Babaian, MD, Professor, Department of Urology
  • Trouble Spots: Early Detection Is Key to the Successful Treatment of Melanoma

• 

  OncoLog, Volume 47, Number 02, February 2002

  Kerry L. Wright and Charles F. Leverbeck MD

  • Molecular Therapies Target Bone Metastasis
  • "I'm Here to Help You" Patient Advocates Serve as Liaisons Between Patients and Care Centers
  • DiaLog: Patient Advocates: Solving Problems and Building Bridges, by Charles F. Leverback, MD, Associate Professor, Department of Gynecologic Oncology
  • House Call: Keeping the Heart Healthy in Patients with Cancer

• 

  OncoLog, Volume 47, Number 01, January 2002

  Dawn Chalaire and Mariann Crapanzano

  • Preserving and Restoring the Ability to Swallow in Patients with Head and Neck Cancer Requires a Team Approach
  • Modified Barium Swallow Helps Speech Pathologists Determine What Patients Are Able to Eat
  • House Call: Common Cancers, Common Symptoms
  • Portal Vein Embolization Offers More Pateints an Opportunity for Potentially Curative Hepatic Resection

• 

  OncoLog, Volume 46, Number 11/12, November-December 2001

  Karen Stuyck and Kerry L. Wright

  • Multidisciplinary Team Helps Patients with Cancer Overcome Cognitive Problems
  • Protocols: Studies Focus on Cognitive Effects of Cancer and Its Treatment
  • House Call: Simple Steps Can Put Patients on the Road to Well-Being
  • Highly Selective Synthetic Binding Agents Target Different DNA Conformations

• 

  OncoLog, Volume 46, Number 10, October 2001

  Dawn Chalaire; Kerry L. Wright; and Mary K. Hughes MS, RN

  • Surgical Techniques, New Agents Target Breast Disease with Increasing Accuracy
  • Undiagnosed Breast Clinic Provides Answers for Concerned Patients
  • House Call: Tips for Coping with the Cosmetic Effects of Breast Cancer
  • DiaLog: Breast Cancer and Body Image, by Mary K. Hughes, MS, RN, Department of Psychiatry
  • New Screening and Diagnostic Techniques Are Changing the Practice of Breast Imaging

• 

  OncoLog, Volume 46, Number 09, September 2001

  Beth Notzon, Kerry L. Wright, and Renato Lenzi MD

  • Completing the Job: Multidisciplinary Effort Restores Form and Function, Improves Patients' Quality of Life
  • House Call: Denial and Cancer
  • Protocols: Studies Examine Treatments for Glioma
  • DiaLog: Addressing the Problem of Patients' Denial, by Renato Lenzi, MD, Associate Professor, Department of Gastrointestinal Medical Oncology
  • New Replication-Competent Adenovirus Shows Promise against Gliomas in Preclinical Studies

• 

  OncoLog, Volume 46, Number 07/08, July/August 2001

  Mariann Crapanzano, Noelle Heinze, and Wendeline Jongenberger MBA

  • Chemoprevention Researchers Look for Ways to Halt the Process of Carcinogenesis
  • House Call: HPV and Cancer: What Every Woman--and Man--Should Know
  • Chemoprevention Trial Targets Former Smokers
  • DiaLog: Serving International Clients, by Wendeline Jongenberger, MBA, Director, International Programs
  • Protocols: Chemoprevention Clinical Trials

• 

  OncoLog, Volume 46, Number 06, June 2001

  Kathryn Hale and Dawn Chalaire

  • Bladder Cancer Genetic Mapping Effort Builds on Human Genome Project
  • Protocols: Clinical Trials for Bladder Cancer
  • Keeping in Touch: Office of Physician Relations Builds Partnerships, Maintains Contact with Community Physicians
  • House Call: Overcoming Barriers to Cancer Screening for Men

• 

  OncoLog, Volume 46, Number 05, May 2001

  Kate O'Suilleabhain; Roy S. Herbst MD, PhD; and Kerry L. Wright

  • Antiangiogenic Agents: Changing the Nature of Cancer Treatment
  • DiaLog: Angiogenesis Research: Looking for New Ways to Measure Success, by Roy S. Herbst, MD, PhD, Assistant Professor, Department of Thoracic/Head and Neck Medical Oncology
  • House Call: Overcome Fears of Cancer Recurrence by Taking Action
  • Recognition Spurs Prevention of Osteoporosis in Patients with Cancer
  • Protocols: Clinical Trials of Antiangiogenic Agents

• 

  OncoLog, Volume 46, Number 04, April 2001

  Kerry L. Wright, Don Norwood, Dawn Chalaire, and Julie Penne

  • Clinical PET Facility Returns to M.D. Anderson
  • Trial Shows Pill Is as Effective as Intravenous Chemotherapy for Advanced Colon Cancer
  • House Call: After Cancer: A Survivor's Diary
  • Postirradiation Oral Complications Are Serious but Preventable

• 

  OncoLog, Volume 46, Number 03, March 2001

  Dawn Chalaire; Beth Notzon; Janette Weaver; Leonard A. Zwelling MD, MBA; and Kerry L. Wright

  • Researchers Examine Link Between Stress and Response to Cancer Treatment
  • Emotional Side Effects: Section of Behavioral Medicine in Department of Pediatrics Helps Patients and Their Families Cope with Cancer
  • House Call: Getting the Facts About Clinical Trials
  • DiaLog: Where Patient Care and Research Meet, by Leonard A. Zwelling, MD, MBA, Vice President for Research Administration
  • Moving Toward Recovery: Exercise Video Features Adolescents with Cancer

• 

  OncoLog, Volume 46, Number 02, February 2001

  Sunni Hosemann, Kerry L. Wright, and Janet M. Bruner MD

  • Specialized Training and Techniques of Pathologists Lead to Targeted Therapies
  • Protocols: Studies Examine High-Dose Chemotherapy for Breast Cancer
  • High-Dose Chemotherapy for Breast Cancer: Completion of Clinical Trials Necessary
  • DiaLog: Many Specialties, One Goal, by Janet M. Bruner, MD, Chairman, Department of Pathology
  • House Call: Support Groups Offer Patients a Helping Hand
  • Study Reveals Types of Diagnostic Errors and Their Costs

• 

  OncoLog, Volume 46, Number 01, January 2001

  Kerry L. Wright, Dawn Chalaire, and Emil J. Freireich MD

  • New Melanoma Staging System Reflects Key Prognostic Factors
  • House Cell: Preventing Cancer: Food for Thought
  • Educational Conferences Explore Issues Related to Cancer Care and Research
  • DiaLog: Leukemia: Setting the "Stage" for Effective Treatments, by Emil J. Freireich, MD, Professor, Department of Leukemia
  • Updated M. D. Anderson Website Designed to Meet the Online Needs of Patients and Physicians

• 

  OncoLog, Volume 45, Number 12, December 2000

  Sunni Hosemann, Noelle Heinze, and Alison Rufffin

  • And Cancer Too: Treating Cancer Alongside Other Conditions
  • Compass: Clinical Practice Guidelines
  • New Study Measures the Effects of Mood and Hereditary Tendencies to Smoke on Tobacco Cessation
  • House Call: How to Talk with Your Doctor
  • Controlling Infections in Patients with Neutropenia Remains a Challenge

• 

  OncoLog, Volume 45, Number 11, November 2000

  Rebecca Gershenson Smith, Kerry L. Wright, Kris Muller, and Sima Jeha MD

  • Program Addresses Medical, Psychosocial Needs of Young People with Cancer
  • DiaLog: Coming of Age ... with Cancer, by Sima Jeha, MD, Medical Director, Adolescent and Young Adult Program
  • House Call: Cancer Screening: Early Detection Does Make a Difference
  • Endostatin: Phase I Trial Yields Promising Preliminary Results
  • Molecular Radiosensitizers Target Proliferation and Apoptosis Pathways in Tumor Cells

• 

  OncoLog, Volume 45, Number 10, October 2000

  Jude Richard, Dawn Chalaire, Kerry L. Wright, and Alfred A. Merwald DMin

  • Early Consultations with Specialists Increase Patients' Voice Restoration Options After Total Laryngectomy
  • Protocols: Small Cell Lung Cancer Clinical Trials
  • House Call: Unconventional Cancer Treatments: Many Promises but Little Evidence
  • Reunions Give Lung Cancer Survivors an Opportunity to Celebrate
  • DiaLog: Treating Mind, Body, and Spirit, by The Rev. Alfred A. Merwald, D. Min., Director of Chaplaincy and Pastoral Education
  • Experience Leads to More Effective Treatment for Limited-Stage Small Cell Lung Cancer

• 

  OncoLog, Volume 45, Number 09, September 2000

  Mariann Crapanzano, Kerry L. Wright, and David L. Callender MD

  • Multidisciplinary Care Improves Treatment, Enhances Quality of Life for Patients with Colorectal Cancer
  • DiaLog: Treating Cancer with a Team Approach, by David L. Callender, MD, Senior Vice President and Chief Medical Officer
  • Cervical Cancer Prevention: Could Spectroscopy Steal the Spot"light"?
  • Virtual Colonoscopy a Potential Screening Reality
  • Protocols: Clinical Trials for Colorectal Cancer
  • Compass: Clinical Practice Guidelines
  • House Call: Sharing Personal Stories: Books Written by People with Cancer

• 

  OncoLog, Volume 45, Number 07/08, July/August 2000

  Kerry L. Wright, Dawn Chalaire, and Rebecca D. Pentz PhD

  • Advances Allow Expanded Use of Allogeneic Stem Cell Transplantation
  • Use of Umbilical Cord Blood Expands Option of Transplantation to More Children
  • House Call: Meeting Your Own Needs While Caring For Someone Else
  • Protecting the Interests of Young Donors, by Rebecca Pentz, PhD, Clinical Ethicist
  • Protocols: Clinical Trials of Allogeneic Stem Cell Transplants

• 

  OncoLog, Volume 45, Number 06, June 2000

  Kerry L. Wright; Margaret E. Goode; Jack Roth MD; and Gary S. Clayman MD, DDS

  • Newly Organized Ophthalmology Section Expands Treatment of Ocular Malignancies
  • Turning Knowledge Into Effective Gene Therapies, by Jack A. Roth, MD, Professor, Department of Thoracic and Cardiovascular Surgery, and Gary S. Clayman, MD, DDS, Associate Professor, Head and Neck Surgery
  • Microarrays Reduce Time, Labor, and Cost of DNA Analysis
  • New DNA Microarray Technology Could Speed Up Discovery of the Genetic Causes of Lung Cancer
  • House Call: Virtual Health: Finding Reliable Medical Resources on the Internet
  • Clinical Practice Guidelines: Case Report: Ovarian Cancer
  • Protocols: Studies Aim to Detect and Treat Ocular Malignancies

• 

  OncoLog, Volume 45, Number 05, May 2000

  Kerry L. Wright; Stephanie Deming; and Gordon B. Mills MD, PhD

  • Early Detection of Melanoma Spread May Increase Survival Benefits of Adjuvant Therapy
  • No Easy Answers: Women at Increased Risk for Breast Cancer Face Difficult Choices
  • DiaLog: Understanding Risk: A Prerequisite for Making Informed Decisions, by Gordon B. Mills, MD, PhD, Chairman, Department of Molecular Therapeutics
  • House Call: Looking for Trouble: How to Spot Signs of Melanoma
  • Protocols: Melanoma Clinical Trials
  • Biochemotherapy Means Hope for Patients with Advanced Melanoma

• 

  OncoLog, Volume 45, Number 04, April 2000

  Don Norwood; Kerry L. Wright; Ellen R. Gritz PhD; and Alexander V. Prokhorov MD, PhD

  • Rise in Incidence, Associated Diseases Complicate Screening for Esophageal Cancer
  • DiaLog: Preventing Cancers of the Upper Aerodigestive Trad: Challenges for Clinicians, by Ellen R. Gritz, PhD, Professor and Chair, Department of Behavioral Science, and Alexander V. Prokhorov, MD, PhD, Assistant Professor, Department of Behavioral Science
  • House Call: Gene Therapy: Changing the Way Cancer Cells Behave
  • Efforts in Thyroid Cancer Treatment Include Initiation of Multicenter Clinical Trials
  • Preclinical Studies Examine Strategies to Fight Rare Forms of Thyroid Cancer
  • Protocols: Clinical Trials for Esophageal Cancer

• 

  OncoLog, Volume 45, Number 03, March 2000

  Jude Richard, Kerry L. Wright, and Charles S. Cleeland PhD

  • Dental Oncologists Prepare Patients with Head and Neck Cancer for Radiation Therapy
  • DiaLog: Nurses Bring Personal Touch to Clinical Research, by Charles S. Cleeland, PhD, Professor, Pain Research Group, Division of Anesthesiology and Critical Care
  • House Call: Coping with Chemotherapy
  • Radiofrequency Ablation Surpasses Cryoablation as the Treatment of Choice for Localized, Unresectable Liver Malignancies

• 

  OncoLog, Volume 45, Number 02, February 2000

  Kerry L. Wright and Mariann Crapanzano

  • National Cooperation Leads to New Standard of Treatment for Cervical Cancer
  • House Call: Stress and Cancer: What's the Connection?
  • Researchers Study Hormone Intervention Therapy to Prevent Treatment-Induced Sterility
  • Protocols: Cervical Cancer Clinical Trials
  • Regular Pap Smears Still Key to Preventing Cervical Cancer

• 

  OncoLog, Volume 45, Number 01, January 2000

  Dawn Chalaire, Kerry L. Wright, and Rena Sellin MD

  • Pediatric Brain Tumor Studies Focus on Reducing Side Effects, Locating Biological Targets
  • Retinoid Chemoprevention Trial Aims to Reverse Genetic Changes Caused by Smoking
  • DiaLog: Surviving Cancer and Staying Healthy, by Rena Sellin, MD, Professor, Department of Internal Medicine Specialties
  • House Call: From Biopsy to Diagnosis: Understanding the Process
  • Protocols: Pediatric Brain Tumor Clinical Trials
  • Protocols: Chemoprevention Studies Feature a Variety of Agents

• 

  OncoLog, Volume 44, Number 12, December 1999

  Margaret E. Goode, Dawn Chalaire, and John Mendelsohn MD

  • Collaboration Between Scientists, Clinicians Moves Apoptosis Studies Forward
  • Answering the Who, What, and How of Medical Physics
  • USHERING IN NEW TECHNOLOGIES: Medical Physicists Focus on IMRT, Ultrasound-Guided Brachytherapy
  • DiaLog: Building Better Patient Care on the Foundation of Scientific Research, by John Mendelsohn, MD, President, Professor of Clinical Investigation
  • House Call: Make Cancer Prevention Part of Your New Year's Resolutions

• 

  OncoLog, Volume 44, Number 11, November 1999

  Beth Notzon, Dawn Chalaire, and Rhonda L. Moore PhD

  • Overcoming Side Effects: Department of Internal Medicine Specialties Finds Ways to Continue Critical Treatments
  • Partners in Knowledge, News in Cancer: P.I.K.N.I.C. Program Brings Physicians, Patients Together
  • House Call: CIS: Answering the Call for Help
  • Advances in Control of Nausea, Vomiting Aim to Reduce 'Misery Quotient'
  • DiaLog: Finding Meaning in Stories of Pain and Suffering, by Rhonda L. Moore, PhD, Postdoctoral Fellow, Department of Epidemiology
  • Protocols: Side Effects of Cancer and Cancer Treatments Are the Subject of Clinical Investigations